{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:27:46Z","timestamp":1790872066424,"version":"4.1.0"},"reference-count":295,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,28]]},"DOI":"10.7759\/cureus.81353","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T14:26:55Z","timestamp":1743172015000},"source":"Crossref","is-referenced-by-count":2,"title":["A Comprehensive Review of Electrolyte Imbalances and Their Applied Aspects in Dermatology"],"prefix":"10.7759","author":[{"given":"KavyaDeepu","family":"R.M.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohnish","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2010.8.2.72","article-title":"Fluid and electrolyte disturbances in critically ill patients","volume":"8","author":"Lee JW","year":"2010","unstructured":"Lee JW. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press. 2010, 8:72-81. 10.5049\/EBP.2010.8.2.72","journal-title":"Electrolyte Blood Press"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241486","article-title":"Serum electrolytes disorder and its associated factors among adults admitted with metabolic syndrome in Jimma Medical Center, South West Ethiopia: Facility based crossectional study","volume":"15","author":"Timerga A","year":"2020","unstructured":"Timerga A, Kelta E, Kenenisa C, Zawdie B, Habte A, Haile K. Serum electrolytes disorder and its associated factors among adults admitted with metabolic syndrome in Jimma Medical Center, South West Ethiopia: Facility based crossectional study. PLoS One. 2020, 15:e0241486. 10.1371\/journal.pone.0241486","journal-title":"PLoS One"},{"key":"ref3","article-title":"The Regulation of Sodium and Chloride Balance","author":"Seldin DW","year":"1990","unstructured":"Seldin DW, Giebisch G. The Regulation of Sodium and Chloride Balance. Raven Press, New York; 1990."},{"key":"ref4","article-title":"Hyponatremia and Hypoosmalar Disorders","author":"Verbalis JG","year":"2018","unstructured":"Verbalis JG. Hyponatremia and Hypoosmalar Disorders. National Kidney Foundation\u2019s Primer on Kidney Diseases, 7th edn. Gilbert SJ, Weiner DE (ed): Elsevier, 2018. 68-76."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu040","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"29","author":"Spasovski G","year":"2014","unstructured":"Spasovski G, Vanholder R, Allolio B, et al.. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant. 2014, 29:i1-39. 10.1093\/ndt\/gfu040","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct1206321","article-title":"Hyperosmolar therapy for raised intracranial pressure","volume":"367","author":"Ropper AH","year":"2012","unstructured":"Ropper AH. Hyperosmolar therapy for raised intracranial pressure. N Engl J Med. 2012, 367:746-52. 10.1056\/NEJMct1206321","journal-title":"N Engl J Med"},{"key":"ref7","article-title":"Diagnosis and management of sodium disorders: hyponatremia and hypernatremia","volume":"1","author":"Braun MM","year":"2015","unstructured":"Braun MM, Barstow CH, Pyzocha NJ. Diagnosis and management of sodium disorders: hyponatremia and hypernatremia. Am Fam Phys. 2015, 1:299-307.","journal-title":"Am Fam Phys"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.18007","article-title":"Acute skin failure: concept, causes, consequences and care","volume":"71","author":"Inamadar AC","year":"2005","unstructured":"Inamadar AC, Palit A. Acute skin failure: concept, causes, consequences and care. Indian J Dermatol Venereol Leprol. 2005, 71:379-85. 10.4103\/0378-6323.18007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref9","article-title":"Critical Care; Fluid, Electrolyte and Acid-Base Balance; Blood Transfusion. Bailey and Love\u2019s Short Practice of Surgery","author":"Langford RM","year":"2000","unstructured":"Langford RM, Mythen MC. Critical Care; Fluid, Electrolyte and Acid-Base Balance; Blood Transfusion. Bailey and Love\u2019s Short Practice of Surgery. Russel RCG, Williams NS, Bulstrode CJK (ed): Arnold, London; 2000."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1987.01660330067010","article-title":"Treatment of toxic epidermal necrolysis. Cr\u00e9teil's experience","volume":"123","author":"Revuz J","year":"1987","unstructured":"Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R. Treatment of toxic epidermal necrolysis. Cr\u00e9teil's experience. Arch Dermatol. 1987, 123:1156-8. 10.1001\/archderm.1987.01660330067010","journal-title":"Arch Dermatol"},{"key":"ref11","article-title":"Intensive Care in Dermatology","author":"Roujeau JC","year":"1990","unstructured":"Roujeau JC, Revuz J. Intensive Care in Dermatology. Recent Advances in Dermatology. Champion RH, Pye RJ (ed): Churchill-Livingstone, Edinberg; 1990. 85-99."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.04.040","article-title":"Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): a case series of 8 patients highlighting different clinical manifestations","volume":"75","author":"Iyer JG","year":"2016","unstructured":"Iyer JG, Parvathaneni K, Bhatia S, et al.. Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): a case series of 8 patients highlighting different clinical manifestations. J Am Acad Dermatol. 2016, 75:541-7. 10.1016\/j.jaad.2016.04.040","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.876","article-title":"Paraneoplastic syndrome of inappropriate antidiuretic hormone mimicking limbic encephalitis","volume":"68","author":"Blondin NA","year":"2011","unstructured":"Blondin NA, Vortmeyer AO, Harel NY. Paraneoplastic syndrome of inappropriate antidiuretic hormone mimicking limbic encephalitis. Arch Neurol. 2011, 68:1591-4. 10.1001\/archneurol.2011.876","journal-title":"Arch Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2000.tb02190.x","article-title":"Postoperative hyponatremia in a patient with ACTH-producing Merkel cell carcinoma","volume":"27","author":"Anzai S","year":"2000","unstructured":"Anzai S, Sato T, Takayasu S, Asada Y, Terashi H, Takasaki S. Postoperative hyponatremia in a patient with ACTH-producing Merkel cell carcinoma. J Dermatol. 2000, 27:397-400. 10.1111\/j.1346-8138.2000.tb02190.x","journal-title":"J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000255724","article-title":"Paraneoplastic SIADH and dermatomyositis in cervical cancer: a case report and literature review","volume":"2","author":"Jones G","year":"2009","unstructured":"Jones G, Razdan D, Cracchiolo B, Houck K, Sharer L. Paraneoplastic SIADH and dermatomyositis in cervical cancer: a case report and literature review. Case Rep Oncol. 2009, 2:203-9. 10.1159\/000255724","journal-title":"Case Rep Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.55729\/2000-9666.1109","article-title":"A rare case of paraneoplastic syndrome of inappropriate secretion of antidiuretic hormone in cervical squamous cell carcinoma; a case report and literature review","volume":"12","author":"Yucel D","year":"2022","unstructured":"Yucel D, Mekheal E, Kania B, Aron P, Kapoor A, Tailor RP, Maroules M. A rare case of paraneoplastic syndrome of inappropriate secretion of antidiuretic hormone in cervical squamous cell carcinoma; a case report and literature review. J Community Hosp Intern Med Perspect. 2022, 12:119-23. 10.55729\/2000-9666.1109","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5325.233","article-title":"Carcinoma of bronchus with hyponatraemia and dermatomyositis","volume":"1","author":"Williams RT","year":"1963","unstructured":"Williams RT. Carcinoma of bronchus with hyponatraemia and dermatomyositis. Br Med J. 1963, 1:233-6. 10.1136\/bmj.1.5325.233","journal-title":"Br Med J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.08.007","article-title":"Dermatomyositis associated with hyponatremia and anasarca","volume":"16","author":"Grinnell M","year":"2021","unstructured":"Grinnell M, Keyes E, Vazquez T, et al.. Dermatomyositis associated with hyponatremia and anasarca. JAAD Case Rep. 2021, 16:86-9. 10.1016\/j.jdcr.2021.08.007","journal-title":"JAAD Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-019-2122-8","article-title":"Syndrome of inappropriate antidiuretic hormone secretion and Leser-Tr\u00e9lat syndrome as uncommon paraneoplastic manifestations of renal malignancy - a geriatric experience: a case report","volume":"13","author":"Nyanti L","year":"2019","unstructured":"Nyanti L, Samsudin A, Tiong IK. Syndrome of inappropriate antidiuretic hormone secretion and Leser-Tr\u00e9lat syndrome as uncommon paraneoplastic manifestations of renal malignancy - a geriatric experience: a case report. J Med Case Rep. 2019, 13:188. 10.1186\/s13256-019-2122-8","journal-title":"J Med Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.17925\/USN.2020.16.1.66","article-title":"Porphyria-induced recurrent quadriplegia misdiagnosed as Guillain-Barr\u00e9 syndrome","volume":"16","author":"Rad N","year":"2020","unstructured":"Rad N, Beydoun SR. Porphyria-induced recurrent quadriplegia misdiagnosed as Guillain-Barr\u00e9 syndrome. US Neurol. 2020, 16:66-9. 10.17925\/USN.2020.16.1.66","journal-title":"US Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-1529","article-title":"Management of hyponatremia associated with acute porphyria-proposal for the use of tolvaptan","volume":"8","author":"Solares I","year":"2020","unstructured":"Solares I, Tejedor M, Jeric\u00f3 D, Morales-Conejo M, Enr\u00edquez de Salamanca R, Fontanellas A, Tejedor-Jorge A. Management of hyponatremia associated with acute porphyria-proposal for the use of tolvaptan. Ann Transl Med. 2020, 8:1098. 10.21037\/atm-20-1529","journal-title":"Ann Transl Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.15406\/unoaj.2015.02.00034","article-title":"Three cases of acute porphyria, presenting with severe hyponatremia","volume":"2","author":"Zakharova EV","year":"2015","unstructured":"Zakharova EV. Three cases of acute porphyria, presenting with severe hyponatremia. Urol Nephrol Open Access J. 2015, 2:55-9. 10.15406\/unoaj.2015.02.00034","journal-title":"Urol Nephrol Open Access J"},{"key":"ref23","article-title":"Case of atopic dermatitis in infant treated with Chinese herbal medicines and NSAIDs ointment, which induced weight loss, electrolyte disturbance and hypoproteinemia","volume":"62","author":"Yasutomi M","year":"2013","unstructured":"Yasutomi M, Okazaki S, Kawakita A, et al.. Case of atopic dermatitis in infant treated with Chinese herbal medicines and NSAIDs ointment, which induced weight loss, electrolyte disturbance and hypoproteinemia. Arerugi. 2013, 62:827-32.","journal-title":"Arerugi"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/adc.65.2.231","article-title":"Atopic eczema, hyponatraemia, and hypoalbuminaemia","volume":"65","author":"Goodyear HM","year":"1990","unstructured":"Goodyear HM, Harper JI. Atopic eczema, hyponatraemia, and hypoalbuminaemia. Arch Dis Child. 1990, 65:231-2. 10.1136\/adc.65.2.231","journal-title":"Arch Dis Child"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/ped.13865","article-title":"Hyponatremia secondary to severe atopic dermatitis in early infancy","volume":"61","author":"Adachi M","year":"2019","unstructured":"Adachi M, Takamasu T, Inuo C. Hyponatremia secondary to severe atopic dermatitis in early infancy. Pediatr Int. 2019, 61:544-50. 10.1111\/ped.13865","journal-title":"Pediatr Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2017.1419975","article-title":"HIV\/AIDS-related hyponatremia: an old but still serious problem","volume":"40","author":"Shu Z","year":"2018","unstructured":"Shu Z, Tian Z, Chen J, Ma J, Abudureyimu A, Qian Q, Zhuo L. HIV\/AIDS-related hyponatremia: an old but still serious problem. Ren Fail. 2018, 40:68-74. 10.1080\/0886022X.2017.1419975","journal-title":"Ren Fail"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17155320","article-title":"Hyponatremia in infectious diseases-a literature review","volume":"17","author":"Kr\u00f3licka AL","year":"2020","unstructured":"Kr\u00f3licka AL, Kruczkowska A, Krajewska M, Kusztal MA. Hyponatremia in infectious diseases-a literature review. Int J Environ Res Public Health. 2020, 17:10.3390\/ijerph17155320","journal-title":"Int J Environ Res Public Health"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.60359","article-title":"Mucocutaneous manifestations of Dengue fever","volume":"55","author":"Thomas EA","year":"2010","unstructured":"Thomas EA, John M, Kanish B. Mucocutaneous manifestations of Dengue fever. Indian J Dermatol. 2010, 55:79-85. 10.4103\/0019-5154.60359","journal-title":"Indian J Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S237168","article-title":"Hyponatremia as an inflammatory marker of lupus activity is a fact or fad: a cross-sectional study","volume":"12","author":"Yamany A","year":"2020","unstructured":"Yamany A, Behiry ME, Ahmed SA. Hyponatremia as an inflammatory marker of lupus activity is a fact or fad: a cross-sectional study. Open Access Rheumatol. 2020, 12:29-34. 10.2147\/OARRR.S237168","journal-title":"Open Access Rheumatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.01173.x","article-title":"Clinico-pathological analysis of the cutaneous lesions of a patient with type I pseudohypoaldosteronism","volume":"19","author":"Mart\u00edn JM","year":"2005","unstructured":"Mart\u00edn JM, Calduch L, Monteagudo C, Alonso V, Garc\u00eda L, Jord\u00e1 E. Clinico-pathological analysis of the cutaneous lesions of a patient with type I pseudohypoaldosteronism. J Eur Acad Dermatol Venereol. 2005, 19:377-9. 10.1111\/j.1468-3083.2004.01173.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.02936.x","article-title":"Newborn with pseudohypoaldosteronism and miliaria rubra","volume":"45","author":"Akcakus M","year":"2006","unstructured":"Akcakus M, Koklu E, Poyrazoglu H, Kurtoglu S. Newborn with pseudohypoaldosteronism and miliaria rubra. Int J Dermatol. 2006, 45:1432-4. 10.1111\/j.1365-4632.2006.02936.x","journal-title":"Int J Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195810","article-title":"Pathophysiology of drug-induced hyponatremia","volume":"11","author":"Kim GH","year":"2022","unstructured":"Kim GH. Pathophysiology of drug-induced hyponatremia. J Clin Med. 2022, 11:10.3390\/jcm11195810","journal-title":"J Clin Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2013.05.009","article-title":"Aldosterone regulates Na(+), K(+) ATPase activity in human renal proximal tubule cells through mineralocorticoid receptor","volume":"1833","author":"Salyer SA","year":"2013","unstructured":"Salyer SA, Parks J, Barati MT, Lederer ED, Clark BJ, Klein JD, Khundmiri SJ. Aldosterone regulates Na(+), K(+) ATPase activity in human renal proximal tubule cells through mineralocorticoid receptor. Biochim Biophys Acta. 2013, 1833:2143-52. 10.1016\/j.bbamcr.2013.05.009","journal-title":"Biochim Biophys Acta"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/096120339900800617","article-title":"Intravenous immunoglobulin infusion causing pseudohyponatremia","volume":"8","author":"Ng SK","year":"1999","unstructured":"Ng SK. Intravenous immunoglobulin infusion causing pseudohyponatremia. Lupus. 1999, 8:488-90. 10.1177\/096120339900800617","journal-title":"Lupus"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10325","article-title":"Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia","volume":"73","author":"Steinberger BA","year":"2003","unstructured":"Steinberger BA, Ford SM, Coleman TA. Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia. Am J Hematol. 2003, 73:97-100. 10.1002\/ajh.10325","journal-title":"Am J Hematol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-006-0416-9","article-title":"True hyponatremia secondary to intravenous immunoglobulin","volume":"10","author":"Nguyen MK","year":"2006","unstructured":"Nguyen MK, Rastogi A, Kurtz I. True hyponatremia secondary to intravenous immunoglobulin. Clin Exp Nephrol. 2006, 10:124-6. 10.1007\/s10157-006-0416-9","journal-title":"Clin Exp Nephrol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/08860220601166644","article-title":"Colchicine overdose-induced acute renal failure and electrolyte imbalance","volume":"29","author":"Huang WH","year":"2007","unstructured":"Huang WH, Hsu CW, Yu CC. Colchicine overdose-induced acute renal failure and electrolyte imbalance. Ren Fail. 2007, 29:367-70. 10.1080\/08860220601166644","journal-title":"Ren Fail"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011200","article-title":"Antidepressants and the risk of hyponatremia: a Danish register-based population study","volume":"6","author":"Leth-M\u00f8ller KB","year":"2016","unstructured":"Leth-M\u00f8ller KB, Hansen AH, Torstensson M, et al.. Antidepressants and the risk of hyponatremia: a Danish register-based population study. BMJ Open. 2016, 6:e011200. 10.1136\/bmjopen-2016-011200","journal-title":"BMJ Open"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23536","article-title":"An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)","volume":"9","author":"Ezoe Y","year":"2018","unstructured":"Ezoe Y, Mizusawa J, Katayama H, Kataoka K, Muto M. An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A). Oncotarget. 2018, 9:6595-606. 10.18632\/oncotarget.23536","journal-title":"Oncotarget"},{"key":"ref40","article-title":"Burns","author":"Levi B","year":"2019","unstructured":"Levi B, Wang S. Burns. Fitzpatrick\u2019s Dermatology, 9th edn. Kang S, Amagai M, Bruckner AL, Alexander H, Margolis DJ, McMichael JS (ed): McGraw-Hill Education, New York; 2019. 1687."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.01.500","article-title":"Vismodegib-associated hyponatremia and ileus: Implication for surgery and patient management","volume":"70","author":"Strasswimmer J","year":"2014","unstructured":"Strasswimmer J. Vismodegib-associated hyponatremia and ileus: Implication for surgery and patient management. J Am Acad Dermatol. 2014, 70:120. 10.1016\/j.jaad.2014.01.500","journal-title":"J Am Acad Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.30.15_suppl.e18558","article-title":"A phase I\/II trial of melphalan (MEL) combined with panobinostat (PAN) for patients with relapsed or refractory (R\/R) multiple myeloma","volume":"30","author":"Yellin O","year":"2012","unstructured":"Yellin O, Berenson JR, Boccia RV, et al.. A phase I\/II trial of melphalan (MEL) combined with panobinostat (PAN) for patients with relapsed or refractory (R\/R) multiple myeloma. J Clin Oncol. 2012, 30:e18558. 10.1200\/jco.2012.30.15_suppl.e18558","journal-title":"J Clin Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12749","article-title":"Hyponatremia and MAP-kinase inhibitors in malignant melanoma: frequency, pathophysiological aspects and clinical consequences","volume":"32","author":"Assan F","year":"2019","unstructured":"Assan F, Vilaine E, Wagner S, et al.. Hyponatremia and MAP-kinase inhibitors in malignant melanoma: frequency, pathophysiological aspects and clinical consequences. Pigment Cell Melanoma Res. 2019, 32:326-31. 10.1111\/pcmr.12749","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-016-1062-9","article-title":"Extreme hypernatremia as a probable cause of fatal arrhythmia: a case report","volume":"10","author":"Arambewela MH","year":"2016","unstructured":"Arambewela MH, Somasundaram NP, Garusinghe C. Extreme hypernatremia as a probable cause of fatal arrhythmia: a case report. J Med Case Rep. 2016, 10:272. 10.1186\/s13256-016-1062-9","journal-title":"J Med Case Rep"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-017-9420-5","article-title":"Clinical aspects of changes in water and sodium homeostasis in the elderly","volume":"18","author":"Koch CA","year":"2017","unstructured":"Koch CA, Fulop T. Clinical aspects of changes in water and sodium homeostasis in the elderly. Rev Endocr Metab Disord. 2017, 18:49-66. 10.1007\/s11154-017-9420-5","journal-title":"Rev Endocr Metab Disord"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.0694","article-title":"Practical events in the management of a collodion baby","volume":"151","author":"Nguyen MA","year":"2015","unstructured":"Nguyen MA, Gelman A, Norton SA. Practical events in the management of a collodion baby. JAMA Dermatol. 2015, 151:1031-2. 10.1001\/jamadermatol.2015.0694","journal-title":"JAMA Dermatol"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.5812\/ijp-129542","article-title":"Management of hypernatremia dehydration in three neonates with ichthyosis","volume":"33","author":"Sangsari R","year":"2023","unstructured":"Sangsari R, Saeedi M, Mirnia K. Management of hypernatremia dehydration in three neonates with ichthyosis. Iran J Pediatr. 2023, 33:129542.","journal-title":"Iran J Pediatr"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/srt.12048","article-title":"Transepidermal water loss in erythrodermic patients of various aetiologies","volume":"19","author":"Mohd Noor N","year":"2013","unstructured":"Mohd Noor N, Hussein SH. Transepidermal water loss in erythrodermic patients of various aetiologies. Skin Res Technol. 2013, 19:320-3. 10.1111\/srt.12048","journal-title":"Skin Res Technol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3205\/000119","article-title":"Does hypernatremia impact mortality in toxic epidermal necrolysis?","volume":"8","author":"Namdar T","year":"2010","unstructured":"Namdar T, von Wild T, Siemers F, Stollwerck PL, Stang FH, Mail\u00e4nder P, Lange T. Does hypernatremia impact mortality in toxic epidermal necrolysis?. Ger Med Sci. 2010, 8:Doc30. 10.3205\/000119","journal-title":"Ger Med Sci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin S","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000, 115:149-53. 10.1046\/j.1523-1747.2000.00061.x","journal-title":"J Invest Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061841","article-title":"Importance of redox equilibrium in the pathogenesis of psoriasis-impact of antioxidant-rich diet","volume":"12","author":"Winiarska-Mieczan A","year":"202020","unstructured":"Winiarska-Mieczan A, Mieczan T, W\u00f3jcik G. Importance of redox equilibrium in the pathogenesis of psoriasis-impact of antioxidant-rich diet. Nutrients. 202020, 12:1841. 10.3390\/nu12061841","journal-title":"Nutrients"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.06.013","article-title":"Skin sodium accumulates in psoriasis and reflects disease severity","volume":"142","author":"Maifeld A","year":"2022","unstructured":"Maifeld A, Wild J, Karlsen TV, et al.. Skin sodium accumulates in psoriasis and reflects disease severity. J Invest Dermatol. 2022, 142:166-78.e8. 10.1016\/j.jid.2021.06.013","journal-title":"J Invest Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/nature11868","article-title":"Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells","volume":"496","author":"Kleinewietfeld M","year":"2013","unstructured":"Kleinewietfeld M, Manzel A, Titze J, et al.. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature. 2013, 496:518-22. 10.1038\/nature11868","journal-title":"Nature"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI81151","article-title":"Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells","volume":"125","author":"Hernandez AL","year":"2015","unstructured":"Hernandez AL, Kitz A, Wu C, et al.. Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J Clin Invest. 2015, 125:4212-22. 10.1172\/JCI81151","journal-title":"J Clin Invest"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00440","article-title":"Could sodium chloride be an environmental trigger for immune-mediated diseases? An overview of the experimental and clinical evidence","volume":"9","author":"Toussirot E","year":"2018","unstructured":"Toussirot E, B\u00e9reau M, Vauchy C, Saas P. Could sodium chloride be an environmental trigger for immune-mediated diseases? An overview of the experimental and clinical evidence. Front Physiol. 2018, 9:440. 10.3389\/fphys.2018.00440","journal-title":"Front Physiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-013-0912-7","article-title":"Hypernatremia-related miliaria crystallina","volume":"18","author":"Chao CT","year":"2014","unstructured":"Chao CT. Hypernatremia-related miliaria crystallina. Clin Exp Nephrol. 2014, 18:831-2. 10.1007\/s10157-013-0912-7","journal-title":"Clin Exp Nephrol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12055","article-title":"Widespread miliaria crystallina in a newborn with hypernatremic dehydration","volume":"30","author":"Eng\u00fcr D","year":"2013","unstructured":"Eng\u00fcr D, T\u00fcrkmen MK, Savk E. Widespread miliaria crystallina in a newborn with hypernatremic dehydration. Pediatr Dermatol. 2013, 30:e234-5. 10.1111\/pde.12055","journal-title":"Pediatr Dermatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.4274\/haseki.galenos.2022.8612","article-title":"Diffuse miliaria Cristalina due to severe hypernatremic dehydration: a neonatal case report with a current literature review","volume":"60","author":"Aydin B","year":"2022","unstructured":"Aydin B, Botan E. Diffuse miliaria Cristalina due to severe hypernatremic dehydration: a neonatal case report with a current literature review. Med Bull Haseki. 2022, 60:494-7. 10.4274\/haseki.galenos.2022.8612","journal-title":"Med Bull Haseki"},{"key":"ref59","article-title":"\ufeff\ufeff\ufeff\ufeff\ufeffImpact of hypernatremia on burn wound healing: results of an exploratory, retrospective study","volume":"57","author":"Namdar T","year":"2011","unstructured":"Namdar T, Stollwerck PL, Stang FH, Eisenbeiss W, Siemers F, Mailander P, Lange T. \ufeff\ufeff\ufeff\ufeff\ufeffImpact of hypernatremia on burn wound healing: results of an exploratory, retrospective study. Ostomy Wound Manage. 2011, 57:30-4.","journal-title":"Ostomy Wound Manage"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1159\/000346206","article-title":"Dysnatremias and survival in adult burn patients: a retrospective analysis","volume":"37","author":"Stewart IJ","year":"2013","unstructured":"Stewart IJ, Morrow BD, Tilley MA, et al.. Dysnatremias and survival in adult burn patients: a retrospective analysis. Am J Nephrol. 2013, 37:59-64. 10.1159\/000346206","journal-title":"Am J Nephrol"},{"key":"ref61","article-title":"Hypernatremia risk factors and prognostic impact in burn patients: a case control study","volume":"34","author":"Sedghiani I","year":"2021","unstructured":"Sedghiani I, Mokline A, Fredj H, et al.. Hypernatremia risk factors and prognostic impact in burn patients: a case control study. Ann Burns Fire Disasters. 2021, 34:135-9.","journal-title":"Ann Burns Fire Disasters"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1993.02160310018006","article-title":"Fatal hypernatremia in an infant due to salting of the skin","volume":"147","author":"Yercen N","year":"1993","unstructured":"Yercen N, Caglayan S, Y\u00fccel N, Yaprak I, Og\u00fcn A, Unver A. Fatal hypernatremia in an infant due to salting of the skin. Am J Dis Child. 1993, 147:716-7. 10.1001\/archpedi.1993.02160310018006","journal-title":"Am J Dis Child"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-009-1123-9","article-title":"Severe hypernatremia in newborns due to salting","volume":"169","author":"Peker E","year":"2010","unstructured":"Peker E, Kirimi E, Tuncer O, Ceylan A. Severe hypernatremia in newborns due to salting. Eur J Pediatr. 2010, 169:829-32. 10.1007\/s00431-009-1123-9","journal-title":"Eur J Pediatr"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808133390707","article-title":"Hypokalemia","volume":"339","author":"Gennari FJ","year":"1998","unstructured":"Gennari FJ. Hypokalemia. N Engl J Med. 1998, 339:451-8. 10.1056\/NEJM199808133390707","journal-title":"N Engl J Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.4103\/ijcep.ijcep_43_17","article-title":"Potassium homeostasis, oxidative stress, and human disease","volume":"4","author":"Udensi UK","year":"2017","unstructured":"Udensi UK, Tchounwou PB. Potassium homeostasis, oxidative stress, and human disease. Int J Clin Exp Physiol. 2017, 4:111-22. 10.4103\/ijcep.ijcep_43_17","journal-title":"Int J Clin Exp Physiol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0109","article-title":"Hypokalemia: a clinical update","volume":"7","author":"Kardalas E","year":"2018","unstructured":"Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: a clinical update. Endocr Connect. 2018, 7:R135-46. 10.1530\/EC-18-0109","journal-title":"Endocr Connect"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06781.x","article-title":"Diet and psoriasis: experimental data and clinical evidence","volume":"153","author":"Wolters M","year":"2005","unstructured":"Wolters M. Diet and psoriasis: experimental data and clinical evidence. Br J Dermatol. 2005, 153:706-14. 10.1111\/j.1365-2133.2005.06781.x","journal-title":"Br J Dermatol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1945.01510240044009","article-title":"Low potassium diet in treatment of psoriasis","volume":"51","author":"Lewinn EB","year":"1945","unstructured":"Lewinn EB, Urbach E. Low potassium diet in treatment of psoriasis. Arch Derm Syphilol. 1945, 51:398-401. 10.1001\/archderm.1945.01510240044009","journal-title":"Arch Derm Syphilol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2008.09.031","article-title":"Psoriasis and vegetarian diets: a role for cortisol and potassium?","volume":"72","author":"Rastmanesh R","year":"2009","unstructured":"Rastmanesh R. Psoriasis and vegetarian diets: a role for cortisol and potassium?. Med Hypotheses. 2009, 72:368. 10.1016\/j.mehy.2008.09.031","journal-title":"Med Hypotheses"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.74.5.1569172","article-title":"Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome","volume":"74","author":"Ulick S","year":"1992","unstructured":"Ulick S, Wang JZ, Blumenfeld JD, Pickering TG. Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab. 1992, 74:963-7. 10.1210\/jcem.74.5.1569172","journal-title":"J Clin Endocrinol Metab"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i22.7989","article-title":"Ectopic Cushing's syndrome in a patient with metastatic Merkel cell carcinoma: a case report","volume":"10","author":"Ishay A","year":"2022","unstructured":"Ishay A, Touma E, Vornicova O, Dodiuk-Gad R, Goldman T, Bisharat N. Ectopic Cushing's syndrome in a patient with metastatic Merkel cell carcinoma: a case report. World J Clin Cases. 2022, 10:7989-93. 10.12998\/wjcc.v10.i22.7989","journal-title":"World J Clin Cases"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-36-3-482","article-title":"Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis","volume":"36","author":"Carey RM","year":"1973","unstructured":"Carey RM, Orth DN, Hartmann WH. Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis. J Clin Endocrinol Metab. 1973, 36:482-7. 10.1210\/jcem-36-3-482","journal-title":"J Clin Endocrinol Metab"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v5.i1.33","article-title":"Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients","volume":"5","author":"Musso CG","year":"2016","unstructured":"Musso CG, Belloso WH, Glassock RJ. Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients. World J Nephrol. 2016, 5:33-42. 10.5527\/wjn.v5.i1.33","journal-title":"World J Nephrol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-023-03131-3","article-title":"Steroid-induced hypokalemic periodic paralysis: a case report and literature review","volume":"24","author":"Tai HT","year":"2023","unstructured":"Tai HT, Lee PT, Ou SH. Steroid-induced hypokalemic periodic paralysis: a case report and literature review. BMC Nephrol. 2023, 24:70. 10.1186\/s12882-023-03131-3","journal-title":"BMC Nephrol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730080-00009","article-title":"Drug-induced endocrine and metabolic disorders","volume":"30","author":"Ben Salem C","year":"2007","unstructured":"Ben Salem C, Slim R, Elouni B, Hmouda H, Bouraoui K. Drug-induced endocrine and metabolic disorders. Drug Saf. 2007, 30:727-8; author reply 728-9. 10.2165\/00002018-200730080-00009","journal-title":"Drug Saf"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.ijem_159_23","article-title":"Incidence, risk factors and prognosis of hypokalaemia in patients with Normokalaemia at hospital admission","volume":"27","author":"Bhargava J","year":"2023","unstructured":"Bhargava J, Viswanathan S. Incidence, risk factors and prognosis of hypokalaemia in patients with Normokalaemia at hospital admission. Indian J Endocrinol Metab. 2023, 27:537-43. 10.4103\/ijem.ijem_159_23","journal-title":"Indian J Endocrinol Metab"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000095469.21361.39","article-title":"Severe hypokalemia and rhabdomyolysis associated with itraconazole therapy","volume":"22","author":"Ruiz-Contreras J","year":"2003","unstructured":"Ruiz-Contreras J, Rodriguez R, G\u00f3mez de Quero P, Gonz\u00e1lez Tom\u00e9 MI, S\u00e1nchez D\u00edaz JI. Severe hypokalemia and rhabdomyolysis associated with itraconazole therapy. Pediatr Infect Dis J. 2003, 22:1024-5. 10.1097\/01.inf.0000095469.21361.39","journal-title":"Pediatr Infect Dis J"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(89)92657-3","article-title":"Hypokalaemia in patients with acute myeloid leukaemia after treatment with fluconazole","volume":"6","author":"Kidd D","year":"1989","unstructured":"Kidd D, Ranaghan EA, Morris TC. Hypokalaemia in patients with acute myeloid leukaemia after treatment with fluconazole. Lancet. 1989, 6:1. 10.1016\/s0140-6736(89)92657-3","journal-title":"Lancet"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-17-0157","article-title":"Mineralocorticoid hypertension and hypokalaemia induced by posaconazole","volume":"2018","author":"Boughton C","year":"2018","unstructured":"Boughton C, Taylor D, Ghataore L, Taylor N, Whitelaw BC. Mineralocorticoid hypertension and hypokalaemia induced by posaconazole. Endocrinol Diabetes Metab Case Rep. 2018, 2018:17-0157. 10.1530\/EDM-17-0157","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.10.002. Epub 2012 Nov 2","article-title":"Acyclovir induced hypokalemia","volume":"56","author":"Drawz PE","year":"2013","unstructured":"Drawz PE, Perez F, Bonomo RA. Acyclovir induced hypokalemia. J Clin Virol. 2013, 56:177-8. 10.1016\/j.jcv.2012.10.002. Epub 2012 Nov 2","journal-title":"J Clin Virol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pit048. Epub 2013 Aug 9","article-title":"Ganciclovir, Foscarnet, and Cidofovir: antiviral drugs not just for cytomegalovirus","volume":"2","author":"Upadhyayula S","year":"2013","unstructured":"Upadhyayula S, Michaels MG. Ganciclovir, Foscarnet, and Cidofovir: antiviral drugs not just for cytomegalovirus. J Pediatric Infect Dis Soc. 2013, 2:286-90. 10.1093\/jpids\/pit048. Epub 2013 Aug 9","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X17741010","article-title":"Hypokalemia: a potentially life-threatening complication of tenofovir therapy","volume":"5","author":"Koratala A","year":"2017","unstructured":"Koratala A, Ruchi R. Hypokalemia: a potentially life-threatening complication of tenofovir therapy. SAGE Open Med Case Rep. 2017, 5:2050313X17741010. 10.1177\/2050313X17741010","journal-title":"SAGE Open Med Case Rep"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.4081\/oncol.2021.547","article-title":"The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patients: a literature review","volume":"15","author":"Prenggono MD","year":"2021","unstructured":"Prenggono MD, Yasmina A, Ariyah M, Wanahari TA, Hasrianti N. The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patients: a literature review. Oncol Rev. 2021, 15:547. 10.4081\/oncol.2021.547","journal-title":"Oncol Rev"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(03)00224-0","article-title":"Tubular function in patients with hypokalemia induced by sirolimus after renal transplantation","volume":"35","author":"Morales JM","year":"2003","unstructured":"Morales JM, Andr\u00e9s A, Dominguez-Gil B, et al.. Tubular function in patients with hypokalemia induced by sirolimus after renal transplantation. Transplant Proc. 2003, 35:154-6. 10.1016\/s0041-1345(03)00224-0","journal-title":"Transplant Proc"},{"key":"ref85","article-title":"Panobinostat (Farydak): a novel option for the treatment of relapsed or relapsed and refractory multiple myeloma","volume":"41","author":"Moore D","year":"2016","unstructured":"Moore D. Panobinostat (Farydak): a novel option for the treatment of relapsed or relapsed and refractory multiple myeloma. P T. 2016, 41:296-300.","journal-title":"P T"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.10.019","article-title":"A novel form of renal tubular acidosis associated with immune checkpoint inhibitors","volume":"8","author":"Shah CV","year":"2023","unstructured":"Shah CV, Lee HW, Clapp WL, Weiner ID. A novel form of renal tubular acidosis associated with immune checkpoint inhibitors. Kidney Int Rep. 2023, 8:197-201. 10.1016\/j.ekir.2022.10.019","journal-title":"Kidney Int Rep"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2016.09.055","article-title":"Adverse renal effects of novel molecular oncologic targeted therapies: a narrative review","volume":"2","author":"Jhaveri KD","year":"2017","unstructured":"Jhaveri KD, Wanchoo R, Sakhiya V, Ross DW, Fishbane S. Adverse renal effects of novel molecular oncologic targeted therapies: a narrative review. Kidney Int Rep. 2017, 2:108-23. 10.1016\/j.ekir.2016.09.055","journal-title":"Kidney Int Rep"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(59)90209-8","article-title":"Salicylate intoxication with special reference to the development of hypokalemia","volume":"26","author":"Robin ED","year":"1959","unstructured":"Robin ED, Davis RP, Rees SB. Salicylate intoxication with special reference to the development of hypokalemia. Am J Med. 1959, 26:869-82. 10.1016\/0002-9343(59)90209-8","journal-title":"Am J Med"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1699-3","article-title":"Pathogenesis, diagnosis and management of hyperkalemia","volume":"26","author":"Lehnhardt A","year":"2011","unstructured":"Lehnhardt A, Kemper MJ. Pathogenesis, diagnosis and management of hyperkalemia. Pediatr Nephrol. 2011, 26:377-84. 10.1007\/s00467-010-1699-3","journal-title":"Pediatr Nephrol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1991.tb00427.x","article-title":"Adrenocortical insufficiency with normal serum cortisol levels and hyporeninaemia in a patient with acquired immunodeficiency syndrome (AIDS)","volume":"230","author":"Cobbs R","year":"1991","unstructured":"Cobbs R, Pepper GM, Torres JG, Gruenspan HL. Adrenocortical insufficiency with normal serum cortisol levels and hyporeninaemia in a patient with acquired immunodeficiency syndrome (AIDS). J Intern Med. 1991, 230:179-81. 10.1111\/j.1365-2796.1991.tb00427.x","journal-title":"J Intern Med"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90171-9","article-title":"Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome","volume":"82","author":"Kalin MF","year":"1987","unstructured":"Kalin MF, Poretsky L, Seres DS, Zumoff B. Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome. Am J Med. 1987, 82:1035-8. 10.1016\/0002-9343(87)90171-9","journal-title":"Am J Med"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.6509","article-title":"Cotrimoxazole-induced hyperkalemia in renal transplant patient-case report","volume":"10","author":"Srikaram P","year":"2022","unstructured":"Srikaram P, Siddiqui A, Gul F, Deuja P, Fatima N. Cotrimoxazole-induced hyperkalemia in renal transplant patient-case report. Clin Case Rep. 2022, 10:e6509. 10.1002\/ccr3.6509","journal-title":"Clin Case Rep"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.3109\/00365549209048410","article-title":"Cardiac arrest during treatment of Pneumocystis carinii pneumonia with intravenous pentamidine isethionate","volume":"24","author":"Balslev U","year":"1992","unstructured":"Balslev U, Berild D, Nielsen TL. Cardiac arrest during treatment of Pneumocystis carinii pneumonia with intravenous pentamidine isethionate. Scand J Infect Dis. 1992, 24:111-2. 10.3109\/00365549209048410","journal-title":"Scand J Infect Dis"},{"key":"ref94","article-title":"Kidney disease and HIV infection","volume":"25","author":"Wyatt CM","year":"2017","unstructured":"Wyatt CM. Kidney disease and HIV infection. Top Antivir Med. 2017, 25:13-6.","journal-title":"Top Antivir Med"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1975.47","article-title":"Interstitial immune complex nephritis in patients with systemic lupus erythematosus","volume":"7","author":"Brentjens JR","year":"1975","unstructured":"Brentjens JR, Sepulveda M, Baliah T, et al.. Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int. 1975, 7:342-50. 10.1038\/ki.1975.47","journal-title":"Kidney Int"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1988.00380020141019","article-title":"Mechanisms of hyperkalemia in systemic lupus erythematosus","volume":"148","author":"Lee FO","year":"1988","unstructured":"Lee FO, Quismorio FP Jr, Troum OM, Anderson PW, Do YS, Hsueh WA. Mechanisms of hyperkalemia in systemic lupus erythematosus. Arch Intern Med. 1988, 148:397-401. 10.1001\/archinte.1988.00380020141019","journal-title":"Arch Intern Med"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-90-5-783","article-title":"Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism","volume":"90","author":"Tan SY","year":"1979","unstructured":"Tan SY, Shapiro R, Franco R, Stockard H, Mulrow PJ. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann Intern Med. 1979, 90:783-5. 10.7326\/0003-4819-90-5-783","journal-title":"Ann Intern Med"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_658_22","article-title":"Propranolol-induced hyperkalemia in infantile hemangioma patients: how serious is it?","volume":"11","author":"Alakeel A","year":"2022","unstructured":"Alakeel A, Alsalman H, Alotaibi G, Somily H, Alsohime F. Propranolol-induced hyperkalemia in infantile hemangioma patients: how serious is it?. J Family Med Prim Care. 2022, 11:6944-8. 10.4103\/jfmpc.jfmpc_658_22","journal-title":"J Family Med Prim Care"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.01.028","article-title":"Propranolol-induced hyperkalemia in the management of infantile hemangioma","volume":"6","author":"Al-Rwebah H","year":"2020","unstructured":"Al-Rwebah H, Alkhodair R, Al-Khenaizan S. Propranolol-induced hyperkalemia in the management of infantile hemangioma. JAAD Case Rep. 2020, 6:359-61. 10.1016\/j.jdcr.2020.01.028","journal-title":"JAAD Case Rep"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_627_17","article-title":"Topical timolol in PHACES syndrome: is it safe?","volume":"84","author":"Pandhi D","year":"2018","unstructured":"Pandhi D, Jakhar D, Tandon A, Singal A. Topical timolol in PHACES syndrome: is it safe?. Indian J Dermatol Venereol Leprol. 2018, 84:488-91. 10.4103\/ijdvl.IJDVL_627_17","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.07.006","article-title":"Hyperkalemia due to topical timolol for hemangioma","volume":"17","author":"Alasmari B","year":"2023","unstructured":"Alasmari B, Alkhenaizan A, Al-Khenaizan S. Hyperkalemia due to topical timolol for hemangioma. JAAD Case Rep. 2023, 17:53-4. 10.1016\/j.jdcr.2023.07.006","journal-title":"JAAD Case Rep"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.03.038","article-title":"Hyperkalemia caused by penicillin","volume":"121","author":"Thiele A","year":"2008","unstructured":"Thiele A, Rehman HU. Hyperkalemia caused by penicillin. Am J Med. 2008, 121:e1-2. 10.1016\/j.amjmed.2008.03.038","journal-title":"Am J Med"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.293","article-title":"Renal complications of nonsteroidal anti-inflammatory drugs","volume":"44","author":"Schlondorff D","year":"1993","unstructured":"Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int. 1993, 44:643-53. 10.1038\/ki.1993.293","journal-title":"Kidney Int"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20132377","article-title":"Use of potassium iodide in dermatology: updates on an old drug","volume":"88","author":"Costa RO","year":"2013","unstructured":"Costa RO, Macedo PM, Carvalhal A, Bernardes-Engemann AR. Use of potassium iodide in dermatology: updates on an old drug. An Bras Dermatol. 2013, 88:396-402. 10.1590\/abd1806-4841.20132377","journal-title":"An Bras Dermatol"},{"key":"ref105","article-title":"Is there a clinically relevant risk of hyperkalemia with topical clascoterone treatment?","volume":"16","author":"Del Rosso J","year":"2023","unstructured":"Del Rosso J, Stein Gold L, Squittieri N, Thiboutot D. Is there a clinically relevant risk of hyperkalemia with topical clascoterone treatment?. J Clin Aesthet Dermatol. 2023, 16:20-4.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912770","article-title":"A Phase 3 trial of Difelikefalin in hemodialysis patients with pruritus","volume":"382","author":"Fishbane S","year":"2020","unstructured":"Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F. A Phase 3 trial of Difelikefalin in hemodialysis patients with pruritus. N Engl J Med. 2020, 382:222-32. 10.1056\/NEJMoa1912770","journal-title":"N Engl J Med"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1097\/01.COT.0000372177.68484.ab","article-title":"Preventing & managing tumor lysis syndrome","volume":"38","author":"Held-Warmkessel J","year":"2010","unstructured":"Held-Warmkessel J. Preventing & managing tumor lysis syndrome. Oncol Times. 2010, 38:1-7. 10.1097\/01.COT.0000372177.68484.ab","journal-title":"Oncol Times"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16921","article-title":"Rituxan-induced tumor lysis syndrome in a patient with diffuse large B-cell lymphoma","volume":"13","author":"Iftikhar S","year":"2021","unstructured":"Iftikhar S, Khokher W, Gekonde J, Kesireddy N, Mudiyanselage P. Rituxan-induced tumor lysis syndrome in a patient with diffuse large B-cell lymphoma. Cureus. 2021, 13:e16921. 10.7759\/cureus.16921","journal-title":"Cureus"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12420","article-title":"Disorders of calcium metabolism: hypocalcemia and hypercalcemia","volume":"13","author":"Tinawi M","year":"2021","unstructured":"Tinawi M. Disorders of calcium metabolism: hypocalcemia and hypercalcemia. Cureus. 2021, 13:e12420. 10.7759\/cureus.12420","journal-title":"Cureus"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine J","year":"2015","unstructured":"Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol. 2015, 10:1257-72. 10.2215\/CJN.09750913","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1007\/BF02722599","article-title":"Hypocalcemia in the newborn","volume":"68","author":"Aggarwal R","year":"2001","unstructured":"Aggarwal R, Upadhyay M, Deorari AK, Paul VK. Hypocalcemia in the newborn. Indian J Pediatr. 2001, 68:973-5. 10.1007\/BF02722599","journal-title":"Indian J Pediatr"},{"key":"ref112","article-title":"Disorders of Calcium, Phosphate, and Magnesium Metabolism","author":"Kestenbaum B","year":"2018","unstructured":"Kestenbaum B, Houillier P. Disorders of Calcium, Phosphate, and Magnesium Metabolism. Comprehensive Clinical Nephrology. Johnson, RJ, Floege, J, Tonelli MComprehensive Clinical Nephrology, 7th edn. Philadelphia, PA (ed): Elsevier, Philadelphia, PA; 2018. 124-41."},{"key":"ref113","article-title":"Hypocalcemia: updates in diagnosis and management for primary care","volume":"58","author":"Fong J","year":"2012","unstructured":"Fong J, Khan A. Hypocalcemia: updates in diagnosis and management for primary care. Can Fam Physician. 2012, 58:158-62.","journal-title":"Can Fam Physician"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2006.04.003","article-title":"Dermatologic manifestations of parathyroid-related disorders","volume":"24","author":"Fuleihan Gel-H","year":"2006","unstructured":"Fuleihan Gel-H, Rubeiz N. Dermatologic manifestations of parathyroid-related disorders. Clin Dermatol. 2006, 24:281-8. 10.1016\/j.clindermatol.2006.04.003","journal-title":"Clin Dermatol"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-5-677","article-title":"Hypocalcemia-induced pustular psoriasis of von Zumbusch. New experience with an old syndrome","volume":"100","author":"Stewart AF","year":"1984","unstructured":"Stewart AF, Battaglini-Sabetta J, Millstone L. Hypocalcemia-induced pustular psoriasis of von Zumbusch. New experience with an old syndrome. Ann Intern Med. 1984, 100:677-80. 10.7326\/0003-4819-100-5-677","journal-title":"Ann Intern Med"},{"key":"ref116","article-title":"Hypocalcemia in impetigo herpetiformis: a secondary transient phenomenon?","volume":"127","author":"Thio HB","year":"1991","unstructured":"Thio HB, Vermeer BJ. Hypocalcemia in impetigo herpetiformis: a secondary transient phenomenon?. Arch Dermatol. 1991, 127:1587-8.","journal-title":"Arch Dermatol"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01293.x","article-title":"Impetigo herpetiformis with hyperparathyroidism","volume":"19","author":"Wolf R","year":"2005","unstructured":"Wolf R, Tartler U, Stege H, Megahed M, Ruzicka T. Impetigo herpetiformis with hyperparathyroidism. J Eur Acad Dermatol Venereol. 2005, 19:743-6. 10.1111\/j.1468-3083.2005.01293.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref118","article-title":"Acute generalized pustular psoriasis and idiopathic hypoparathyroidism in an adolescent girl","volume":"42","author":"Ashkevari S","unstructured":"Ashkevari S, Maboodi A. Acute generalized pustular psoriasis and idiopathic hypoparathyroidism in an adolescent girl. Acta Med Iran. 1, 42:300-2.","journal-title":"Acta Med Iran"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.149","article-title":"Wnt5a\/\u03b2-catenin signaling drives calcium-induced differentiation of human primary keratinocytes","volume":"134","author":"Popp T","year":"2014","unstructured":"Popp T, Steinritz D, Breit A, et al.. Wnt5a\/\u03b2-catenin signaling drives calcium-induced differentiation of human primary keratinocytes. J Invest Dermatol. 2014, 134:2183-91. 10.1038\/jid.2014.149","journal-title":"J Invest Dermatol"},{"key":"ref120","article-title":"Generalized pustular psoriasis with hypoparathyroidism","volume":"9","author":"Kawamura A","year":"1999","unstructured":"Kawamura A, Kinoshita MT, Suzuki H. Generalized pustular psoriasis with hypoparathyroidism. Eur J Dermatol. 1999, 9:574-6.","journal-title":"Eur J Dermatol"},{"key":"ref121","article-title":"Impetigo herpetiformis associated with hypocalcemia of congenital rickets","volume":"127","author":"Holm AL","year":"1991","unstructured":"Holm AL, Goldsmith LA. Impetigo herpetiformis associated with hypocalcemia of congenital rickets. Arch Dermatol. 1991, 127:91-5.","journal-title":"Arch Dermatol"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1159\/000250117","article-title":"Impetigo herpetiformis with lowered serum level of vitamin D and its diminished intestinal absorption","volume":"164","author":"Ott F","year":"1982","unstructured":"Ott F, Krakowski A, Tur E, Lipitz R, Weisman Y, Brenner S. Impetigo herpetiformis with lowered serum level of vitamin D and its diminished intestinal absorption. Dermatologica. 1982, 164:360-5. 10.1159\/000250117","journal-title":"Dermatologica"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.26326\/2281-9649.30.3.2137","article-title":"Childhood psoriasis and serum calcium levels","volume":"30","author":"Maheswari A","year":"2020","unstructured":"Maheswari A, Dutta B. Childhood psoriasis and serum calcium levels. Eur J Pediat Dermatol. 2020, 30:161-66. 10.26326\/2281-9649.30.3.2137","journal-title":"Eur J Pediat Dermatol"},{"key":"ref124","article-title":"Treatment of psoriasis by oral calcitriol. A study of 5 cases and review of the literature","volume":"120","author":"Boisseau-Garsaud AM","year":"1993","unstructured":"Boisseau-Garsaud AM, Legrain V, Hehunstre JP, Maleville J, Ta\u00efeb A. Treatment of psoriasis by oral calcitriol. A study of 5 cases and review of the literature. Ann Dermatol Venereol. 1993, 120:669-74.","journal-title":"Ann Dermatol Venereol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2011.643219","article-title":"Oral vitamin D, still a viable treatment option for psoriasis","volume":"24","author":"Kamangar F","year":"2013","unstructured":"Kamangar F, Koo J, Heller M, Lee E, Bhutani T. Oral vitamin D, still a viable treatment option for psoriasis. J Dermatolog Treat. 2013, 24:261-7. 10.3109\/09546634.2011.643219","journal-title":"J Dermatolog Treat"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.54393\/pjhs.v4i11.1061","article-title":"Frequency of hypocalcemia among patients with moderate to severe chronic plaque psoriasis: chronic plaque psoriasis","volume":"30","author":"Ilyas S","year":"2023","unstructured":"Ilyas S, Mukhtar R, Bashir B, Nusrat W, Ilyas T, Malik LM. Frequency of hypocalcemia among patients with moderate to severe chronic plaque psoriasis: chronic plaque psoriasis. PJHS-Lahore . 2023, 30:148-52. 10.54393\/pjhs.v4i11.1061","journal-title":"PJHS-Lahore"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1049","article-title":"Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry","volume":"16","author":"Manyam BV","year":"2001","unstructured":"Manyam BV, Walters AS, Narla KR. Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord. 2001, 16:258-64. 10.1002\/mds.1049","journal-title":"Mov Disord"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15158","article-title":"Severe hypocalcaemia-related pustular psoriasis in an 83-year-old woman with Fahr's syndrome: a case report","volume":"33","author":"Tissier M","year":"2019","unstructured":"Tissier M, Abou Nakad S, Vignon-Pennamen MD, Lependu C, Bouaziz JD, Groh M. Severe hypocalcaemia-related pustular psoriasis in an 83-year-old woman with Fahr's syndrome: a case report. J Eur Acad Dermatol Venereol. 2019, 33:e42-3. 10.1111\/jdv.15158","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref129","article-title":"Secondary bilateral striopallidodentate calcinosis associated with generalized pustular psoriasis (Von Zumbusch)","volume":"19","author":"Pacheco D","year":"2013","unstructured":"Pacheco D, Travassos AR, Antunes J, Marques MS, Filipe P, Silva R. Secondary bilateral striopallidodentate calcinosis associated with generalized pustular psoriasis (Von Zumbusch). Dermatol Online J. 2013, 19:18569.","journal-title":"Dermatol Online J"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.08.036. Epub 2015 Sep 26","article-title":"Can pretreatment serum calcium level predict the efficacy of methotrexate in the treatment of severe plaque psoriasis?","volume":"73","author":"Zhai Z","year":"2015","unstructured":"Zhai Z, Chen L, Yang H, et al.. Can pretreatment serum calcium level predict the efficacy of methotrexate in the treatment of severe plaque psoriasis?. J Am Acad Dermatol. 2015, 73:991-7. 10.1016\/j.jaad.2015.08.036. Epub 2015 Sep 26","journal-title":"J Am Acad Dermatol"},{"key":"ref131","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1992.01680170058005","article-title":"Serum parathyroid hormone level is elevated in some patients with disorders of keratinization","volume":"128","author":"Milstone LM","year":"1992","unstructured":"Milstone LM, Ellison AF, Insogna KL. Serum parathyroid hormone level is elevated in some patients with disorders of keratinization. Arch Dermatol. 1992, 128:926-30.","journal-title":"Arch Dermatol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.110877","article-title":"Ichthyosis associated with rickets in two Indian children","volume":"58","author":"Kothari D","year":"2013","unstructured":"Kothari D, Doshi B, Garg G, Khopkar US. Ichthyosis associated with rickets in two Indian children. Indian J Dermatol. 2013, 58:244. 10.4103\/0019-5154.110877","journal-title":"Indian J Dermatol"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08355.x","article-title":"Ichthyosiform erythroderma with rickets: report of five cases","volume":"158","author":"Sethuraman G","year":"2008","unstructured":"Sethuraman G, Khaitan BK, Dash SS, et al.. Ichthyosiform erythroderma with rickets: report of five cases. Br J Dermatol. 2008, 158:603-6. 10.1111\/j.1365-2133.2007.08355.x","journal-title":"Br J Dermatol"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.25641","article-title":"Epidermolytic hyperkeratosis with rickets","volume":"72","author":"Nayak S","year":"2006","unstructured":"Nayak S, Behera SK, Acharjya B, Sahu A, Mishra D. Epidermolytic hyperkeratosis with rickets. Indian J Dermatol Venereol Leprol. 2006, 72:139-42. 10.4103\/0378-6323.25641","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref135","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1993.01680260120024","article-title":"Secondary hyperparathyroidism in patients with ichthyosis is not caused by vitamin D deficiency or ingestion of retinoids","volume":"129","author":"Milstone LM","year":"1993","unstructured":"Milstone LM, Ellison AF, Insogna KL. Secondary hyperparathyroidism in patients with ichthyosis is not caused by vitamin D deficiency or ingestion of retinoids. Arch Dermatol. 1993, 129:648.","journal-title":"Arch Dermatol"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00658.x","article-title":"Bullous congenital ichthyosiform erythroderma associated with hypocalcemic vitamin D-resistant rickets","volume":"25","author":"el-Khateeb EA","year":"2008","unstructured":"el-Khateeb EA. Bullous congenital ichthyosiform erythroderma associated with hypocalcemic vitamin D-resistant rickets. Pediatr Dermatol. 2008, 25:279-82. 10.1111\/j.1525-1470.2008.00658.x","journal-title":"Pediatr Dermatol"},{"key":"ref137","article-title":"X-linked dominant chondrodysplasia punctata (CDPX2): multisystemic impact of the defect in cholesterol biosynthesis","volume":"108","author":"Martanov\u00e1 H","year":"2007","unstructured":"Martanov\u00e1 H, Krepelov\u00e1 A, Baxov\u00e1 A, et al.. X-linked dominant chondrodysplasia punctata (CDPX2): multisystemic impact of the defect in cholesterol biosynthesis. Prague Med Rep. 2007, 108:263-9.","journal-title":"Prague Med Rep"},{"key":"ref138","article-title":"Cranial MR imaging in rhizomelic chondrodysplasia punctata","volume":"12","author":"Williams DW 3rd","year":"1991","unstructured":"Williams DW 3rd, Elster AD, Cox TD. Cranial MR imaging in rhizomelic chondrodysplasia punctata. AJNR Am J Neuroradiol. 1991, 12:363-5.","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14979","article-title":"Conradi-H\u00fcnermann-Happle syndrome associated with severe hypocalcemia in a newborn","volume":"39","author":"Dykman M","year":"2022","unstructured":"Dykman M, Voller LM, Boull C. Conradi-H\u00fcnermann-Happle syndrome associated with severe hypocalcemia in a newborn. Pediatr Dermatol. 2022, 39:657-8. 10.1111\/pde.14979","journal-title":"Pediatr Dermatol"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3704","article-title":"A case of HDR syndrome and ichthyosis: dual diagnosis by whole-genome sequencing of novel mutations in GATA3 and STS genes","volume":"101","author":"Goodwin G","year":"2016","unstructured":"Goodwin G, Hawley PP, Miller DT. A case of HDR syndrome and ichthyosis: dual diagnosis by whole-genome sequencing of novel mutations in GATA3 and STS genes. J Clin Endocrinol Metab. 2016, 101:837-40. 10.1210\/jc.2015-3704","journal-title":"J Clin Endocrinol Metab"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1971.04000240058008","article-title":"Albright's hereditary osteodystrophy with cutaneous bone formation","volume":"104","author":"Eyre WG","year":"1971","unstructured":"Eyre WG, Reed WB. Albright's hereditary osteodystrophy with cutaneous bone formation. Arch Dermatol. 1971, 104:634-42. 10.1001\/archderm.1971.04000240058008","journal-title":"Arch Dermatol"},{"key":"ref142","article-title":"A rare case of Albright\u2019s hereditary osteodystrophy presenting as recurrent hypocalcemic tetany","volume":"1","author":"Gomes RR","year":"2022","unstructured":"Gomes RR. A rare case of Albright\u2019s hereditary osteodystrophy presenting as recurrent hypocalcemic tetany. J Genet Heredit Res. 2022, 1:101.","journal-title":"J Genet Heredit Res"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2008.06862.x","article-title":"First diagnosis of Martin-Albright syndrome in a 58-year-old patient","volume":"7","author":"Quist SR","year":"2009","unstructured":"Quist SR, Franke I, Hiort O, Gollnick HP, Leverkus M. First diagnosis of Martin-Albright syndrome in a 58-year-old patient. J Dtsch Dermatol Ges. 2009, 7:43-5. 10.1111\/j.1610-0387.2008.06862.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.09.008","article-title":"GNAQ\/GNA11 mosaicism is associated with abnormal serum calcium indices and microvascular neurocalcification","volume":"144","author":"Kn\u00f6pfel N","year":"2024","unstructured":"Kn\u00f6pfel N, Zecchin D, Richardson H, et al.. GNAQ\/GNA11 mosaicism is associated with abnormal serum calcium indices and microvascular neurocalcification. J Invest Dermatol. 2024, 144:820-32.e9. 10.1016\/j.jid.2023.09.008","journal-title":"J Invest Dermatol"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2016.14.1.74","article-title":"Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy","volume":"14","author":"Aksoy D","year":"2016","unstructured":"Aksoy D, G\u00fcveli BT, Ak PD, Sar\u0131 H, Atakl\u0131 D, Arpac\u0131 B. Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy. Clin Psychopharmacol Neurosci. 2016, 14:74-8. 10.9758\/cpn.2016.14.1.74","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.08.028","article-title":"GNAQ\/GNA11 mosaicism causes aberrant calcium signaling susceptible to targeted therapeutics","volume":"144","author":"Zecchin D","year":"2024","unstructured":"Zecchin D, Kn\u00f6pfel N, Gluck AK, et al.. GNAQ\/GNA11 mosaicism causes aberrant calcium signaling susceptible to targeted therapeutics. J Invest Dermatol. 2024, 144:811-9.e4. 10.1016\/j.jid.2023.08.028","journal-title":"J Invest Dermatol"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1159\/000078591","article-title":"Hypocalcemia: a sign of severity of necrotizing fasciitis","volume":"209","author":"Nakamura S","year":"2004","unstructured":"Nakamura S, Hashimoto Y, Ishida-Yamamoto A, et al.. Hypocalcemia: a sign of severity of necrotizing fasciitis. Dermatology. 2004, 209:64-5. 10.1159\/000078591","journal-title":"Dermatology"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(86)70044-3","article-title":"Necrotizing fasciitis associated with porphyria cutanea tarda","volume":"14","author":"Kranz KR","year":"1986","unstructured":"Kranz KR, Reed OM, Grimwood RE. Necrotizing fasciitis associated with porphyria cutanea tarda. J Am Acad Dermatol. 1986, 14:361-7. 10.1016\/s0190-9622(86)70044-3","journal-title":"J Am Acad Dermatol"},{"key":"ref149","article-title":"Biochemicals markers of risk for mortality in necrotizing fasciitis","volume":"46","author":"Guzm\u00e1n-Aguilar RM","year":"2008","unstructured":"Guzm\u00e1n-Aguilar RM. Biochemicals markers of risk for mortality in necrotizing fasciitis. Rev Med Inst Mex Seguro Soc. 2008, 46:583-90.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2007.00816.x","article-title":"The cutaneous manifestations of atypical complete DiGeorge syndrome: a histopathologic and immunohistochemical study","volume":"35","author":"Selim MA","year":"2008","unstructured":"Selim MA, Markert ML, Burchette JL, Herman CM, Turner JW. The cutaneous manifestations of atypical complete DiGeorge syndrome: a histopathologic and immunohistochemical study. J Cutan Pathol. 2008, 35:380-5. 10.1111\/j.1600-0560.2007.00816.x","journal-title":"J Cutan Pathol"},{"key":"ref151","article-title":"Discussion on a new concept of the cellular basis of immunity","volume":"67","author":"DiGeorge AM","year":"1965","unstructured":"DiGeorge AM. Discussion on a new concept of the cellular basis of immunity. J Pediatr. 1965, 67:907-8.","journal-title":"J Pediatr"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12466","article-title":"Prevalence of hypocalcaemia and its associated features in 22q11\u00b72 deletion syndrome","volume":"81","author":"Cheung EN","year":"2014","unstructured":"Cheung EN, George SR, Costain GA, Andrade DM, Chow EW, Silversides CK, Bassett AS. Prevalence of hypocalcaemia and its associated features in 22q11\u00b72 deletion syndrome. Clin Endocrinol (Oxf). 2014, 81:190-6. 10.1111\/cen.12466","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref153","article-title":"Transverse leukonychia in severe hypocalcemia","volume":"14","author":"Foti C","year":"2004","unstructured":"Foti C, Cassano N, Palmieri VO, et al.. Transverse leukonychia in severe hypocalcemia. Eur J Dermatol. 2004, 14:67-8.","journal-title":"Eur J Dermatol"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1954.tb12552.x","article-title":"Dermatological changes in hypocalcaemia","volume":"66","author":"Simpson JA","year":"1954","unstructured":"Simpson JA. Dermatological changes in hypocalcaemia. Br J Dermatol. 1954, 66:1-15. 10.1111\/j.1365-2133.1954.tb12552.x","journal-title":"Br J Dermatol"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2010.03.037","article-title":"Nutrition and nail disease","volume":"28","author":"Cashman MW","year":"2010","unstructured":"Cashman MW, Sloan SB. Nutrition and nail disease. Clin Dermatol. 2010, 28:420-5. 10.1016\/j.clindermatol.2010.03.037","journal-title":"Clin Dermatol"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1007\/BF02600132","article-title":"Electrolyte and acid-base disorders associated with AIDS: an etiologic review","volume":"9","author":"Perazella MA","year":"1994","unstructured":"Perazella MA, Brown E. Electrolyte and acid-base disorders associated with AIDS: an etiologic review. J Gen Intern Med. 1994, 9:232-6. 10.1007\/BF02600132","journal-title":"J Gen Intern Med"},{"key":"ref157","article-title":"Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature","volume":"15","author":"Quimby D","year":"2005","unstructured":"Quimby D, Brito MO. Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature. AIDS Read. 2005, 15:357-64.","journal-title":"AIDS Read"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-5-1130","article-title":"Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism","volume":"72","author":"Jacobson MA","year":"1991","unstructured":"Jacobson MA, Gambertoglio JG, Aweeka FT, Causey DM, Portale AA. Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J Clin Endocrinol Metab. 1991, 72:1130-5. 10.1210\/jcem-72-5-1130","journal-title":"J Clin Endocrinol Metab"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8270936","article-title":"Severe symptomatic hypocalcemia from HIV related hypoparathyroidism","volume":"2018","author":"Sandhu S","year":"2018","unstructured":"Sandhu S, Desai A, Batra M, et al.. Severe symptomatic hypocalcemia from HIV related hypoparathyroidism. Case Rep Endocrinol. 2018, 2018:8270936. 10.1155\/2018\/8270936","journal-title":"Case Rep Endocrinol"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6060(96)80044-4","article-title":"Expression and function of a CD4-like molecule in parathyroid tissue","volume":"120","author":"Hellman P","year":"1996","unstructured":"Hellman P, Karlsson-Parra A, Klareskog L, et al.. Expression and function of a CD4-like molecule in parathyroid tissue. Surgery. 1996, 120:985-92. 10.1016\/s0039-6060(96)80044-4","journal-title":"Surgery"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211415","article-title":"Subcutaneous fat necrosis associated with severe hypocalcaemia in a neonate","volume":"26","author":"Karochristou K","year":"2006","unstructured":"Karochristou K, Siahanidou T, Kakourou-Tsivitanidou T, Stefanaki K, Mandyla H. Subcutaneous fat necrosis associated with severe hypocalcaemia in a neonate. J Perinatol. 2006, 26:64-6. 10.1038\/sj.jp.7211415","journal-title":"J Perinatol"},{"key":"ref162","article-title":"Subcutaneous fat necrosis of the newborn: clinical manifestations in four cases","volume":"1","author":"Jianping T","year":"2014","unstructured":"Jianping T, Ye S. Subcutaneous fat necrosis of the newborn: clinical manifestations in four cases. Austin J Dermatol. 2014, 1:1017-9.","journal-title":"Austin J Dermatol"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1330151","article-title":"Transient pseudohypoparathyroidism of the neonate","volume":"133","author":"Minagawa M","year":"1995","unstructured":"Minagawa M, Yasuda T, Kobayashi Y, Niimi H. Transient pseudohypoparathyroidism of the neonate. Eur J Endocrinol. 1995, 133:151-5. 10.1530\/eje.0.1330151","journal-title":"Eur J Endocrinol"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1097\/BCR.0b013e3181711152","article-title":"Hypocalcemia, hypomagnesemia, and hypokalemia following hydrofluoric acid chemical injury","volume":"29","author":"Dalamaga M","year":"2008","unstructured":"Dalamaga M, Karmaniolas K, Nikolaidou A, Papadavid E. Hypocalcemia, hypomagnesemia, and hypokalemia following hydrofluoric acid chemical injury. J Burn Care Res. 2008, 29:541-3. 10.1097\/BCR.0b013e3181711152","journal-title":"J Burn Care Res"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1093\/occmed\/51.4.294","article-title":"Hypocalcaemia and hypomagnesaemia due to hydrofluoric acid","volume":"51","author":"Sanz-Gall\u00e9n P","year":"2001","unstructured":"Sanz-Gall\u00e9n P, Nogu\u00e9 S, Munn\u00e9 P, Faraldo A. Hypocalcaemia and hypomagnesaemia due to hydrofluoric acid. Occup Med (Lond). 2001, 51:294-5. 10.1093\/occmed\/51.4.294","journal-title":"Occup Med (Lond)"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-198811000-00015","article-title":"Hydrofluoric acid-induced hypocalcemia","volume":"28","author":"Greco RJ","year":"1988","unstructured":"Greco RJ, Hartford CE, Haith LR Jr, Patton ML. Hydrofluoric acid-induced hypocalcemia. J Trauma. 1988, 28:1593-6. 10.1097\/00005373-198811000-00015","journal-title":"J Trauma"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1016\/s0196-0644(95)70161-3","article-title":"Corticosteroids precipitating hypocalcemic encephalopathy in hypoparathyroidism","volume":"26","author":"Handa R","year":"1995","unstructured":"Handa R, Wali JP, Singh RI, Aggarwal P. Corticosteroids precipitating hypocalcemic encephalopathy in hypoparathyroidism. Ann Emerg Med. 1995, 26:241-2. 10.1016\/s0196-0644(95)70161-3","journal-title":"Ann Emerg Med"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa046.2122","article-title":"Sat-LB309 amphotericin B induced hypocalcemia in a patient with severe hypercalcemia due to acute T-cell leukemia\/lymphoma","volume":"4","author":"Janapala RN","year":"2020","unstructured":"Janapala RN, jayaraj J, Rass B, Zarghamravanbakhsh P, Sachmechi I. Sat-LB309 amphotericin B induced hypocalcemia in a patient with severe hypercalcemia due to acute T-cell leukemia\/lymphoma. J Endocr Soc. 2020, 4:SAT-LB309. 10.1210\/jendso\/bvaa046.2122","journal-title":"J Endocr Soc"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2143-2148.2000","article-title":"A double-blind placebo-controlled crossover trial of intravenous magnesium sulfate for foscarnet-induced ionized hypocalcemia and hypomagnesemia in patients with AIDS and cytomegalovirus infection","volume":"44","author":"Huycke MM","year":"2000","unstructured":"Huycke MM, Naguib MT, Stroemmel MM, Blick K, Monti K, Martin-Munley S, Kaufman C. A double-blind placebo-controlled crossover trial of intravenous magnesium sulfate for foscarnet-induced ionized hypocalcemia and hypomagnesemia in patients with AIDS and cytomegalovirus infection. Antimicrob Agents Chemother. 2000, 44:2143-8. 10.1128\/AAC.44.8.2143-2148.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2013.801300","article-title":"Phenytoin-associated severe hypocalcemia with seizures in a patient with a TSC2-PKD1 contiguous gene syndrome","volume":"35","author":"Nseir G","year":"2013","unstructured":"Nseir G, Golshayan D, Barbey F. Phenytoin-associated severe hypocalcemia with seizures in a patient with a TSC2-PKD1 contiguous gene syndrome. Ren Fail. 2013, 35:866-8. 10.3109\/0886022X.2013.801300","journal-title":"Ren Fail"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1002\/lio2.515","article-title":"Effect of PPIs on symptomatic hypocalcemia after thyroidectomy: a retrospective cohort study","volume":"6","author":"Gerges D","year":"2021","unstructured":"Gerges D, Grohmann N, Trieu V, Brundage W, Sajisevi M. Effect of PPIs on symptomatic hypocalcemia after thyroidectomy: a retrospective cohort study. Laryngoscope Investig Otolaryngol. 2021, 6:150-4. 10.1002\/lio2.515","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-019-00686-z","article-title":"Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes","volume":"33","author":"Louie KS","year":"2020","unstructured":"Louie KS, Erhard C, Wheeler DC, Stenvinkel P, Fouqueray B, Floege J. Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes. J Nephrol. 2020, 33:803-16. 10.1007\/s40620-019-00686-z","journal-title":"J Nephrol"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-016-0543-y","article-title":"A RANKL wrinkle: Denosumab-induced hypocalcemia","volume":"12","author":"Laskowski LK","year":"2016","unstructured":"Laskowski LK, Goldfarb DS, Howland MA, Kavcsak K, Lugassy DM, Smith SW. A RANKL wrinkle: Denosumab-induced hypocalcemia. J Med Toxicol. 2016, 12:305-8. 10.1007\/s13181-016-0543-y","journal-title":"J Med Toxicol"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2008.536","article-title":"Severe symptomatic hypocalcemia in a patient with RDEB treated with intravenous zoledronic acid","volume":"145","author":"Perman MJ","year":"2009","unstructured":"Perman MJ, Lucky AW, Heubi JE, Azizkhan RG. Severe symptomatic hypocalcemia in a patient with RDEB treated with intravenous zoledronic acid. Arch Dermatol. 2009, 145:95-6. 10.1001\/archdermatol.2008.536","journal-title":"Arch Dermatol"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e32836411bc","article-title":"Clinical relevance and utility of cetuximab-related changes in magnesium and calcium serum levels","volume":"24","author":"Stintzing S","year":"2013","unstructured":"Stintzing S, Fischhaber D, Mook C, et al.. Clinical relevance and utility of cetuximab-related changes in magnesium and calcium serum levels. Anticancer Drugs. 2013, 24:969-74. 10.1097\/CAD.0b013e32836411bc","journal-title":"Anticancer Drugs"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V7102056","article-title":"Severe hyperphosphatemia and hypocalcemia: a dilemma in patient management","volume":"7","author":"Sutters M","year":"1996","unstructured":"Sutters M, Gaboury CL, Bennett WM. Severe hyperphosphatemia and hypocalcemia: a dilemma in patient management. J Am Soc Nephrol. 1996, 7:2056-61. 10.1681\/ASN.V7102056","journal-title":"J Am Soc Nephrol"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.935821","article-title":"A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia","volume":"28","author":"Tonon CR","year":"2022","unstructured":"Tonon CR, Silva TA, Pereira FW, et al.. A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia. Med Sci Monit. 2022, 28:e935821. 10.12659\/MSM.935821","journal-title":"Med Sci Monit"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04101.x","article-title":"Medical management of hypercalcaemia","volume":"34","author":"Ralston SH","year":"1992","unstructured":"Ralston SH. Medical management of hypercalcaemia. Br J Clin Pharmacol. 1992, 34:11-20. 10.1111\/j.1365-2125.1992.tb04101.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2003.20315.x","article-title":"Complications of subcutaneous fat necrosis of the newborn: a case report and review of the literature","volume":"20","author":"Tran JT","year":"2003","unstructured":"Tran JT, Sheth AP. Complications of subcutaneous fat necrosis of the newborn: a case report and review of the literature. Pediatr Dermatol. 2003, 20:257-61. 10.1046\/j.1525-1470.2003.20315.x","journal-title":"Pediatr Dermatol"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.1186\/s40348-022-00151-1","article-title":"Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology","volume":"9","author":"Frank L","year":"2022","unstructured":"Frank L, Brandt S, Wabitsch M. Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology. Mol Cell Pediatr. 2022, 9:18. 10.1186\/s40348-022-00151-1","journal-title":"Mol Cell Pediatr"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2017-0365","article-title":"Hypercalcemia, hyperkalemia and supraventricular tachycardia in a patient with subcutaneous fat necrosis","volume":"31","author":"Bahadur KA","year":"2018","unstructured":"Bahadur KA, Johnson S, Lentzner B, Gangat M, Carlson J, Balachandar S. Hypercalcemia, hyperkalemia and supraventricular tachycardia in a patient with subcutaneous fat necrosis. J Pediatr Endocrinol Metab. 2018, 31:469-72. 10.1515\/jpem-2017-0365","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08844.x","article-title":"Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis","volume":"160","author":"Farooque A","year":"2009","unstructured":"Farooque A, Moss C, Zehnder D, Hewison M, Shaw NJ. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis. Br J Dermatol. 2009, 160:423-5. 10.1111\/j.1365-2133.2008.08844.x","journal-title":"Br J Dermatol"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.1177\/000992287000900517","article-title":"Necrosis of subcutaneous fat with hypercalcemia. A puzzling and multifaceted disease","volume":"9","author":"Sharlin DN","year":"1970","unstructured":"Sharlin DN, Koblenzer P. Necrosis of subcutaneous fat with hypercalcemia. A puzzling and multifaceted disease. Clin Pediatr (Phila). 1970, 9:290-4. 10.1177\/000992287000900517","journal-title":"Clin Pediatr (Phila)"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.1042\/cs0830075","article-title":"Increased urinary excretion of prostaglandin E2 in patients with idiopathic hypercalciuria is a primary phenomenon","volume":"83","author":"Henr\u00edquez-La Roche C","year":"1992","unstructured":"Henr\u00edquez-La Roche C, Rodr\u00edguez-Iturbe B, Parra G. Increased urinary excretion of prostaglandin E2 in patients with idiopathic hypercalciuria is a primary phenomenon. Clin Sci (Lond). 1992, 83:75-80. 10.1042\/cs0830075","journal-title":"Clin Sci (Lond)"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-04232-1.50011-6","article-title":"Skin and Lacrimal Drainage System","author":"Yanoff M","year":"2008","unstructured":"Yanoff M, Sassan JW. Skin and Lacrimal Drainage System. Ocular Pathology, 6th edn. Yanoff M, Sassan JW (ed): Elsevier, Edinburgh, UK\/New York, NY; 2008. 165-222. 10.1016\/B978-0-323-04232-1.50011-6"},{"key":"ref186","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70080-y","article-title":"Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodeficiency syndrome and renal disease","volume":"26","author":"Cockerell CJ","year":"1992","unstructured":"Cockerell CJ, Dolan ET. Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodeficiency syndrome and renal disease. J Am Acad Dermatol. 1992, 26:559-62. 10.1016\/0190-9622(92)70080-y","journal-title":"J Am Acad Dermatol"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3818980","article-title":"Calciphylaxis: a long road to cure with a multidisciplinary and multimodal approach","volume":"2022","author":"Zoi V","year":"2022","unstructured":"Zoi V, Bacharaki D, Sardeli A, Karagiannis M, Lionaki S. Calciphylaxis: a long road to cure with a multidisciplinary and multimodal approach. Case Rep Nephrol. 2022, 2022:3818980. 10.1155\/2022\/3818980","journal-title":"Case Rep Nephrol"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.1172\/JCI101084","article-title":"Blood chemical changes in Boeck\u2019s sarcoid with particular reference to protein, calcium and phosphatase values","volume":"18","author":"Harrell GT","year":"1939","unstructured":"Harrell GT, Fisher S. Blood chemical changes in Boeck\u2019s sarcoid with particular reference to protein, calcium and phosphatase values. J Clin Invest. 1939, 18:687-93. 10.1172\/JCI101084","journal-title":"J Clin Invest"},{"key":"ref189","doi-asserted-by":"publisher","DOI":"10.1024\/0040-5930.64.5.281","article-title":"Hypercalcemia in sarcoidosis--case report, prevalence, pathophysiology and therapeutic options","volume":"64","author":"Ackermann D","year":"2007","unstructured":"Ackermann D. Hypercalcemia in sarcoidosis--case report, prevalence, pathophysiology and therapeutic options. Ther Umsch. 2007, 64:281-6. 10.1024\/0040-5930.64.5.281","journal-title":"Ther Umsch"},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10399","article-title":"The Diagnostic dilemma of sarcoidosis: a case of acute hypercalcemia","volume":"12","author":"Mulkareddy V","year":"2020","unstructured":"Mulkareddy V, Bhalla V, Upadhye S, Siddam P. The Diagnostic dilemma of sarcoidosis: a case of acute hypercalcemia. Cureus. 2020, 12:e10399. 10.7759\/cureus.10399","journal-title":"Cureus"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-210189","article-title":"Sarcoidosis-related hypercalcaemia due to production of parathyroid hormone-related peptide","volume":"2015","author":"van Raalte DH","year":"2015","unstructured":"van Raalte DH, Goorden SM, Kemper EA, Brosens LA, ten Kate RW. Sarcoidosis-related hypercalcaemia due to production of parathyroid hormone-related peptide. BMJ Case Rep. 2015, 2015:10.1136\/bcr-2015-210189","journal-title":"BMJ Case Rep"},{"key":"ref192","doi-asserted-by":"publisher","DOI":"10.4158\/EP11060.CR","article-title":"Parathyroid hormone-related protein: an unusual mechanism for hypercalcemia in sarcoidosis","volume":"17","author":"Krikorian A","year":"2011","unstructured":"Krikorian A, Shah S, Wasman J. Parathyroid hormone-related protein: an unusual mechanism for hypercalcemia in sarcoidosis. Endocr Pract. 2011, 17:e84-6. 10.4158\/EP11060.CR","journal-title":"Endocr Pract"},{"key":"ref193","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198412273112607","article-title":"Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis","volume":"311","author":"Gkonos PJ","year":"1984","unstructured":"Gkonos PJ, London R, Hendler ED. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med. 1984, 311:1683-5. 10.1056\/NEJM198412273112607","journal-title":"N Engl J Med"},{"key":"ref194","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-6-890","article-title":"Leprosy, hypercalcemia, and elevated serum calcitriol levels","volume":"105","author":"Hoffman VN","year":"1986","unstructured":"Hoffman VN, Korzeniowski OM. Leprosy, hypercalcemia, and elevated serum calcitriol levels. Ann Intern Med. 1986, 105:890-1. 10.7326\/0003-4819-105-6-890","journal-title":"Ann Intern Med"},{"key":"ref195","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)91033-1","article-title":"Hypercalcemia in disseminated candidiasis","volume":"74","author":"Kantarjian HM","year":"1983","unstructured":"Kantarjian HM, Saad MF, Estey EH, Sellin RV, Samaan NA. Hypercalcemia in disseminated candidiasis. Am J Med. 1983, 74:721-4. 10.1016\/0002-9343(83)91033-1","journal-title":"Am J Med"},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S41520","article-title":"Progressive disseminated histoplasmosis presenting with cachexia and hypercalcemia","volume":"6","author":"Khasawneh FA","year":"2013","unstructured":"Khasawneh FA, Ahmed S, Halloush RA. Progressive disseminated histoplasmosis presenting with cachexia and hypercalcemia. Int J Gen Med. 2013, 6:79-83. 10.2147\/IJGM.S41520","journal-title":"Int J Gen Med"},{"key":"ref197","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.7.532","article-title":"Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease","volume":"279","author":"Bosch X","year":"1998","unstructured":"Bosch X. Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease. JAMA. 1998, 279:532-4. 10.1001\/jama.279.7.532","journal-title":"JAMA"},{"key":"ref198","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002864","article-title":"A case of hypercalcemia in an immunocompetent patient with disseminated Mycobacterium marinum infection with a rain barrel as the most likely primary source","volume":"8","author":"Uijtendaal W","year":"2021","unstructured":"Uijtendaal W, Yohanna R, Visser FW, Ossenkoppele PM, Hess DL, Boumans D. A case of hypercalcemia in an immunocompetent patient with disseminated Mycobacterium marinum infection with a rain barrel as the most likely primary source. Eur J Case Rep Intern Med. 2021, 8:002864. 10.12890\/2021_002864","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9126172","article-title":"Silicone-induced granulomatous reaction causing severe hypercalcemia: case report and literature review","volume":"2019","author":"Dangol GM","year":"2019","unstructured":"Dangol GM, Negrete H. Silicone-induced granulomatous reaction causing severe hypercalcemia: case report and literature review. Case Rep Nephrol. 2019, 2019:9126172. 10.1155\/2019\/9126172","journal-title":"Case Rep Nephrol"},{"key":"ref200","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-217269","article-title":"Calcitriol mediated hypercalcaemia with silicone granulomas due to cosmetic injection","volume":"2016","author":"Melnick S","year":"2016","unstructured":"Melnick S, Abaroa-Salvatierra A, Deshmukh M, Patel A. Calcitriol mediated hypercalcaemia with silicone granulomas due to cosmetic injection. BMJ Case Rep. 2016, 2016:10.1136\/bcr-2016-217269","journal-title":"BMJ Case Rep"},{"key":"ref201","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000001416","article-title":"Hypercalcemia secondary to silicone breast implant rupture: a rare entity to keep in mind","volume":"21","author":"Rodriguez IE","year":"2017","unstructured":"Rodriguez IE, Deleyiannis FW. Hypercalcemia secondary to silicone breast implant rupture: a rare entity to keep in mind. Plast Reconstr Surg Glob Open. 2017, 21:1416. 10.1097\/GOX.0000000000001416","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.12659\/msm.882450","article-title":"Mirror, mirror on the wall: hypercalcemia as a consequence of modern cosmetic treatment with liquid silicone","volume":"18","author":"Schanz J","year":"2012","unstructured":"Schanz J, Flux K, Kircher C, Tsioga M, Hartschuh W, Nawroth PP, Rudofsky G. Mirror, mirror on the wall: hypercalcemia as a consequence of modern cosmetic treatment with liquid silicone. Med Sci Monit. 2012, 18:CS5-7. 10.12659\/msm.882450","journal-title":"Med Sci Monit"},{"key":"ref203","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006968","article-title":"Palisaded neutrophilic and granulomatous dermatitis as a novel cause of hypercalcemia: A case report","volume":"96","author":"Kono M","year":"2017","unstructured":"Kono M, Hasegawa T, Nagai S, et al.. Palisaded neutrophilic and granulomatous dermatitis as a novel cause of hypercalcemia: A case report. Medicine (Baltimore). 2017, 96:e6968. 10.1097\/MD.0000000000006968","journal-title":"Medicine (Baltimore)"},{"key":"ref204","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-JBN-2020-0044","article-title":"Case reports of hypercalcemia and chronic renal disease due to cosmetic injections of polymethylmethacrylate (PMMA)","volume":"43","author":"Manfro AG","year":"2021","unstructured":"Manfro AG, Lutzky M, Dora JM, Kalil MA, Manfro RC. Case reports of hypercalcemia and chronic renal disease due to cosmetic injections of polymethylmethacrylate (PMMA). J Bras Nefrol. 2021, 43:288-92. 10.1590\/2175-8239-JBN-2020-0044","journal-title":"J Bras Nefrol"},{"key":"ref205","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad114.463","article-title":"Fri695 hypercalcemia mediated by granulomatous disease due to polymethylmethacrylate (PMMA) injection utilization for gluteal augmentation","volume":"7","author":"Mishra T","year":"2023","unstructured":"Mishra T, Craven J. Fri695 hypercalcemia mediated by granulomatous disease due to polymethylmethacrylate (PMMA) injection utilization for gluteal augmentation. J Endocr Soc. 2023, 7:bvad114.463. 10.1210\/jendso\/bvad114.463","journal-title":"J Endocr Soc"},{"key":"ref206","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.011155","article-title":"Cancer-related hypercalcemia","volume":"12","author":"Goldner W","year":"2016","unstructured":"Goldner W. Cancer-related hypercalcemia. J Oncol Pract. 2016, 12:426-32. 10.1200\/JOP.2016.011155","journal-title":"J Oncol Pract"},{"key":"ref207","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03280450054026","article-title":"Hypercalcemia in squamous cell carcinoma of the skin","volume":"239","author":"Makoui C","year":"1978","unstructured":"Makoui C, Fishburne C. Hypercalcemia in squamous cell carcinoma of the skin. JAMA. 1978, 239:1882-3. 10.1001\/jama.1978.03280450054026","journal-title":"JAMA"},{"key":"ref208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.08.018","article-title":"Massive squamous cell carcinoma arising from hidradenitis suppurativa with marked hypercalcemia and neutrophilia","volume":"29","author":"Uehara H","year":"2022","unstructured":"Uehara H, Yamaguchi S, Fukai K, Omine T, Miyagi T, Takahashi K. Massive squamous cell carcinoma arising from hidradenitis suppurativa with marked hypercalcemia and neutrophilia. JAAD Case Rep. 2022, 29:9-10. 10.1016\/j.jdcr.2022.08.018","journal-title":"JAAD Case Rep"},{"key":"ref209","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.11.025","article-title":"A fatal case of parathyroid hormone-related peptide (PTHrP)-producing squamous cell carcinoma arising in the context of long-standing hidradenitis suppurativa","volume":"4","author":"Pitch MA","year":"2018","unstructured":"Pitch MA, Bryan DJ, McMillan J, et al.. A fatal case of parathyroid hormone-related peptide (PTHrP)-producing squamous cell carcinoma arising in the context of long-standing hidradenitis suppurativa. JAAD Case Rep. 2018, 4:426-8. 10.1016\/j.jdcr.2017.11.025","journal-title":"JAAD Case Rep"},{"key":"ref210","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/715809","article-title":"Squamous cell carcinoma (Marjolin\u2019s ulcer) arising in a sacral decubitus ulcer resulting in humoral hypercalcemia of malignancy","volume":"2014","author":"O'Malley JT","year":"2014","unstructured":"O'Malley JT, Schoppe C, Husain S, Grossman ME. Squamous cell carcinoma (Marjolin\u2019s ulcer) arising in a sacral decubitus ulcer resulting in humoral hypercalcemia of malignancy. Case Rep Med. 2014, 2014:715809. 10.1155\/2014\/715809","journal-title":"Case Rep Med"},{"key":"ref211","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-008-0554-5","article-title":"Paraneoplastic hypercalcemia caused by an invasive squamous cell carcinoma arising from a giant anal condyloma acuminatum","volume":"24","author":"Hernandez JM","year":"2009","unstructured":"Hernandez JM, Shibata D. Paraneoplastic hypercalcemia caused by an invasive squamous cell carcinoma arising from a giant anal condyloma acuminatum. Int J Colorectal Dis. 2009, 24:359-60. 10.1007\/s00384-008-0554-5","journal-title":"Int J Colorectal Dis"},{"key":"ref212","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-7-251","article-title":"Successful treatment of paraneoplastic hypercalcemia in a patient with giant condyloma acuminatum: a case report","volume":"7","author":"Linnemann T","year":"2013","unstructured":"Linnemann T, M\u00fcller F, L\u00f6hnert M, Hirnle P, G\u00f6rner M. Successful treatment of paraneoplastic hypercalcemia in a patient with giant condyloma acuminatum: a case report. J Med Case Rep. 2013, 7:251. 10.1186\/1752-1947-7-251","journal-title":"J Med Case Rep"},{"key":"ref213","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-200302000-00009","article-title":"Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review","volume":"26","author":"Attia P","year":"2003","unstructured":"Attia P, Phan GQ, Duray PH, Rosenberg SA. Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review. Am J Clin Oncol. 2003, 26:42-5. 10.1097\/00000421-200302000-00009","journal-title":"Am J Clin Oncol"},{"key":"ref214","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2015.09.006","article-title":"Parathyroid hormone-related peptide-linked hypercalcemia in a melanoma patient treated with ipilimumab: hormone source and clinical and metabolic correlates","volume":"42","author":"Mills TA","year":"2015","unstructured":"Mills TA, Orloff M, Domingo-Vidal M, et al.. Parathyroid hormone-related peptide-linked hypercalcemia in a melanoma patient treated with ipilimumab: hormone source and clinical and metabolic correlates. Semin Oncol. 2015, 42:909-14. 10.1053\/j.seminoncol.2015.09.006","journal-title":"Semin Oncol"},{"key":"ref215","doi-asserted-by":"publisher","DOI":"10.1159\/000017960","article-title":"Hypercalcemia in a patient with malignant melanoma arising in congenital giant pigmented nevus. A case of increased serum level of parathyroid hormone-related protein","volume":"197","author":"Matsui T","year":"1998","unstructured":"Matsui T, Kageshita T, Ishihara T, Tomiguchi S, Takahashi M, Ono T. Hypercalcemia in a patient with malignant melanoma arising in congenital giant pigmented nevus. A case of increased serum level of parathyroid hormone-related protein. Dermatology. 1998, 197:65-8. 10.1159\/000017960","journal-title":"Dermatology"},{"key":"ref216","article-title":"Melanoma and primary hyperparathyroidism","volume":"120","author":"Maerens-Tchokokam B","year":"1993","unstructured":"Maerens-Tchokokam B, Bailly N, Collet E, Dalac S, Rat P, Lambert D. Melanoma and primary hyperparathyroidism. Ann Dermatol Venereol. 1993, 120:215-7.","journal-title":"Ann Dermatol Venereol"},{"key":"ref217","doi-asserted-by":"publisher","DOI":"10.1159\/000051733","article-title":"Primary hyperparathyroidism and cutaneous T-cell lymphoma: fortuitous association?","volume":"203","author":"Alb\u00e8s B","year":"2001","unstructured":"Alb\u00e8s B, Bazex J, Bayle-Lebey P, Bennet A, Lamant L. Primary hyperparathyroidism and cutaneous T-cell lymphoma: fortuitous association?. Dermatology. 2001, 203:162-4. 10.1159\/000051733","journal-title":"Dermatology"},{"key":"ref218","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.01033.x","article-title":"Lymphomatoid papulosis associated with parathyroid nodular hyperplasia: report of a case","volume":"18","author":"Aguilar-Bernier M","year":"2004","unstructured":"Aguilar-Bernier M, Bassas-Vila J, Bordel-Gomez MT, Morales-Callaghan A, Tejerina-Garcia JA, Miranda-Romero A. Lymphomatoid papulosis associated with parathyroid nodular hyperplasia: report of a case. J Eur Acad Dermatol Venereol. 2004, 18:693-6. 10.1111\/j.1468-3083.2004.01033.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref219","doi-asserted-by":"publisher","DOI":"10.1159\/000510442","article-title":"Hypercalcemia Associated with Extramammary Paget's Disease","volume":"13","author":"Sato T","year":"2020","unstructured":"Sato T, Wada Y, Kamitani N, Yamamoto T, Aoyama Y, Fujimoto W, Tanaka R. Hypercalcemia Associated with Extramammary Paget's Disease. Case Rep Oncol. 2020, 13:1209-14. 10.1159\/000510442","journal-title":"Case Rep Oncol"},{"key":"ref220","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5332","article-title":"Kasabach-Merritt syndrome combined with hypercalcemia: a case report","volume":"14","author":"Zou R","year":"2017","unstructured":"Zou R, Peng F, Yu T, et al.. Kasabach-Merritt syndrome combined with hypercalcemia: a case report. Exp Ther Med. 2017, 14:6164-8. 10.3892\/etm.2017.5332","journal-title":"Exp Ther Med"},{"key":"ref221","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5458","article-title":"Kaposiform hemangioendothelioma with fatal income: Kasabach-Merritt phenomenon and hypercalcemia","volume":"10","author":"Massara B","year":"2022","unstructured":"Massara B, Mariem R, Emna B, et al.. Kaposiform hemangioendothelioma with fatal income: Kasabach-Merritt phenomenon and hypercalcemia. Clin Case Rep. 2022, 10:e05458. 10.1002\/ccr3.5458","journal-title":"Clin Case Rep"},{"key":"ref222","doi-asserted-by":"publisher","DOI":"10.1159\/000252421","article-title":"Multiple skin and gastro-intestinal haemangiomata (Blue rubber-Bleb Nevus). Report of case with thrombocytopenia, hypercalcemia and coinciding cystic cell carcinoma","volume":"142","author":"Lichtig C","year":"1971","unstructured":"Lichtig C, Alroy G, Gellei B, Valero A. Multiple skin and gastro-intestinal haemangiomata (Blue rubber-Bleb Nevus). Report of case with thrombocytopenia, hypercalcemia and coinciding cystic cell carcinoma. Dermatologica. 1971, 142:356-62. 10.1159\/000252421","journal-title":"Dermatologica"},{"key":"ref223","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2009.12.006","article-title":"Three cases of giant pilomatrixoma--considerations for diagnosis and treatment of giant skin tumours with abundant inner calcification present on the upper body","volume":"63","author":"Yamauchi M","year":"2010","unstructured":"Yamauchi M, Yotsuyanagi T, Saito T, Ikeda K, Urushidate S, Higuma Y. Three cases of giant pilomatrixoma--considerations for diagnosis and treatment of giant skin tumours with abundant inner calcification present on the upper body. J Plast Reconstr Aesthet Surg. 2010, 63:e519-24. 10.1016\/j.bjps.2009.12.006","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"ref224","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/83.2.191","article-title":"The acute and chronic toxic effects of vitamin A","volume":"83","author":"Penniston KL","year":"2006","unstructured":"Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006, 83:191-201. 10.1093\/ajcn\/83.2.191","journal-title":"Am J Clin Nutr"},{"key":"ref225","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6281.1999","article-title":"Vitamin A toxicity and hypercalcaemia in chronic renal failure","volume":"282","author":"Farrington K","year":"1981","unstructured":"Farrington K, Miller P, Varghese Z, Baillod RA, Moorhead JF. Vitamin A toxicity and hypercalcaemia in chronic renal failure. Br Med J (Clin Res Ed). 1981, 282:1999-2002. 10.1136\/bmj.282.6281.1999","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref226","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)91422-5","article-title":"Effects of hypervitaminosis A and D on skeletal metabolism","volume":"239","author":"Clark I","year":"1964","unstructured":"Clark I, Smith MR. Effects of hypervitaminosis A and D on skeletal metabolism. J Biol Chem. 1964, 239:1266-71.","journal-title":"J Biol Chem"},{"key":"ref227","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1977.tb01610.x","article-title":"Vitamin A stimulation of parathyroid hormone: interactions with calcium, hydrocortisone, and vitamin E in bovine parathyroid tissues and effects of vitamin A in man","volume":"7","author":"Chertow BS","year":"1977","unstructured":"Chertow BS, Williams GA, Norris RM, Baker GR, Hargis GK. Vitamin A stimulation of parathyroid hormone: interactions with calcium, hydrocortisone, and vitamin E in bovine parathyroid tissues and effects of vitamin A in man. Eur J Clin Invest. 1977, 7:307-14. 10.1111\/j.1365-2362.1977.tb01610.x","journal-title":"Eur J Clin Invest"},{"key":"ref228","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-374407-4.00480-5","article-title":"Vitamins | Vitamin D","author":"van Staveren W","year":"2011","unstructured":"van Staveren W, de Groot LCPMG. Vitamins | Vitamin D. Encyclopedia of Dairy Sciences, 2nd edn. Fuquay JW (ed): Elsevier, 2011. 646-51. 10.1016\/B978-0-12-374407-4.00480-5"},{"key":"ref229","article-title":"Severe hypercalcemia and systemic lupus erythematosus","volume":"67","author":"Gazzaruso C","year":"2000","unstructured":"Gazzaruso C, Montecucco CM, Geroldi D, Garzaniti A, Finardi G. Severe hypercalcemia and systemic lupus erythematosus. Joint Bone Spine. 2000, 67:485-8.","journal-title":"Joint Bone Spine"},{"key":"ref230","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780391217","article-title":"Hypercalcemia and systemic lupus erythematosus","volume":"39","author":"Deftos LJ","year":"1996","unstructured":"Deftos LJ, Burton DW, Baird SM, Terkeltaub RA. Hypercalcemia and systemic lupus erythematosus. Arthritis Rheum. 1996, 39:2066-9. 10.1002\/art.1780391217","journal-title":"Arthritis Rheum"},{"key":"ref231","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27302004000400017","article-title":"Primary hyperparathyroidism in a patient with systemic lupus erythematosus","volume":"48","author":"Galr\u00e3o LD","year":"2004","unstructured":"Galr\u00e3o LD, Lima IV, Santos L, Santiago MB. Primary hyperparathyroidism in a patient with systemic lupus erythematosus. Arq Bras Endocrinol Metabol. 2004, 48:555-8. 10.1590\/s0004-27302004000400017","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"ref232","article-title":"Review of major endocrine abnormalities in patients with systemic lupus erythematosus","volume":"37","author":"Mu\u00f1oz C","year":"2019","unstructured":"Mu\u00f1oz C, Isenberg DA. Review of major endocrine abnormalities in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2019, 37:791-6.","journal-title":"Clin Exp Rheumatol"},{"key":"ref233","article-title":"Hypercalcemia during the resolution of calcinosis universalis in juvenile dermatomyositis","volume":"18","author":"Ostrov BE","year":"1991","unstructured":"Ostrov BE, Goldsmith DP, Eichenfield AH, Athreya BH. Hypercalcemia during the resolution of calcinosis universalis in juvenile dermatomyositis. J Rheumatol. 1991, 18:1730-4.","journal-title":"J Rheumatol"},{"key":"ref234","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.288.6427","article-title":"Hypercalcaemia during resolution of calcinosis in juvenile dermatomyositis","volume":"5","author":"Wilsher ML","year":"1984","unstructured":"Wilsher ML, Holdaway IM, North JD. Hypercalcaemia during resolution of calcinosis in juvenile dermatomyositis. Br Med J (Clin Res Ed). 1984, 5:1345. 10.1136\/bmj.288.6427","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref235","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v5.i4.230","article-title":"Dermatomyositis associated with gallbladder carcinoma: a case report","volume":"5","author":"Ni QF","year":"2013","unstructured":"Ni QF, Liu GQ, Pu LY, Kong LL, Kong LB. Dermatomyositis associated with gallbladder carcinoma: a case report. World J Hepatol. 2013, 5:230-3. 10.4254\/wjh.v5.i4.230","journal-title":"World J Hepatol"},{"key":"ref236","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2564-4","article-title":"Calcinosis in adult-onset dermatomyositis: metastatic or dystrophic?","volume":"29","author":"Ladizinski B","year":"2014","unstructured":"Ladizinski B, Khan A, Sankey C. Calcinosis in adult-onset dermatomyositis: metastatic or dystrophic?. J Gen Intern Med. 2014, 29:246-7. 10.1007\/s11606-013-2564-4","journal-title":"J Gen Intern Med"},{"key":"ref237","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63005","article-title":"Keratitis-ichthyosis-deafness syndrome with lethal p.Ala88Val variant and severe hypercalcemia","volume":"191","author":"L\u00f3pez-Sundh AE","year":"2023","unstructured":"L\u00f3pez-Sundh AE, Escribano-Palomino E, Feito-Rodr\u00edguez M, et al.. Keratitis-ichthyosis-deafness syndrome with lethal p.Ala88Val variant and severe hypercalcemia. Am J Med Genet A. 2023, 191:253-8. 10.1002\/ajmg.a.63005","journal-title":"Am J Med Genet A"},{"key":"ref238","doi-asserted-by":"publisher","DOI":"10.1002\/jgf2.480","article-title":"Transient hypercalcemia in a patient with SAPHO syndrome","volume":"23","author":"Yoshida T","year":"2022","unstructured":"Yoshida T, Oya M. Transient hypercalcemia in a patient with SAPHO syndrome. J Gen Fam Med. 2022, 23:44-6. 10.1002\/jgf2.480","journal-title":"J Gen Fam Med"},{"key":"ref239","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-003-0465-z","article-title":"Severe hypercalcemia and hypernatremia associated with calcipotriol for treatment of psoriasis","volume":"22","author":"Kawahara C","year":"2004","unstructured":"Kawahara C, Okada Y, Tanikawa T, Fukusima A, Misawa H, Tanaka Y. Severe hypercalcemia and hypernatremia associated with calcipotriol for treatment of psoriasis. J Bone Miner Metab. 2004, 22:159-62. 10.1007\/s00774-003-0465-z","journal-title":"J Bone Miner Metab"},{"key":"ref240","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.159928","article-title":"Vitamin D and skin diseases: a review","volume":"81","author":"Wadhwa B","year":"2015","unstructured":"Wadhwa B, Relhan V, Goel K, Kochhar AM, Garg VK. Vitamin D and skin diseases: a review. Indian J Dermatol Venereol Leprol. 2015, 81:344-55. 10.4103\/0378-6323.159928","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref241","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2003.tb00481.x","article-title":"Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis","volume":"30","author":"Kawaguchi M","year":"2003","unstructured":"Kawaguchi M, Mitsuhashi Y, Kondo S. Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis. J Dermatol. 2003, 30:801-4. 10.1111\/j.1346-8138.2003.tb00481.x","journal-title":"J Dermatol"},{"key":"ref242","article-title":"Physiology, Phosphate","author":"Qadeer HA","year":"2023","unstructured":"Qadeer HA, Bashir K. Physiology, Phosphate.  StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref243","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.07.005","article-title":"Hypophosphatemia: a practical guide to evaluation and management","volume":"28","author":"Tebben PJ","year":"2022","unstructured":"Tebben PJ. Hypophosphatemia: a practical guide to evaluation and management. Endocr Pract. 2022, 28:1091-9. 10.1016\/j.eprac.2022.07.005","journal-title":"Endocr Pract"},{"key":"ref244","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.11.012","article-title":"Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy","volume":"75","author":"Lim YH","year":"2016","unstructured":"Lim YH, Ovejero D, Derrick KM, Collins MT, Choate KA. Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy. J Am Acad Dermatol. 2016, 75:420-7. 10.1016\/j.jaad.2015.11.012","journal-title":"J Am Acad Dermatol"},{"key":"ref245","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(77)80444-7","article-title":"Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions","volume":"91","author":"Aschinberg LC","year":"1977","unstructured":"Aschinberg LC, Solomon LM, Zeis PM, Justice P, Rosenthal IM. Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions. J Pediatr. 1977, 91:56-60. 10.1016\/s0022-3476(77)80444-7","journal-title":"J Pediatr"},{"key":"ref246","doi-asserted-by":"publisher","DOI":"10.1159\/000246861","article-title":"Extensive linear epidermal nevus associated with hemangiomas of bones and vitamin-D-resistant rickets","volume":"189","author":"Stosiek N","year":"1994","unstructured":"Stosiek N, Hornstein OP, Hiller D, Peters KP. Extensive linear epidermal nevus associated with hemangiomas of bones and vitamin-D-resistant rickets. Dermatology. 1994, 189:278-82. 10.1159\/000246861","journal-title":"Dermatology"},{"key":"ref247","doi-asserted-by":"publisher","DOI":"10.1159\/000070948","article-title":"Schimmelpenning-Feuerstein-Mims syndrome with hypophosphatemic rickets","volume":"207","author":"Zutt M","year":"2003","unstructured":"Zutt M, Strutz F, Happle R, et al.. Schimmelpenning-Feuerstein-Mims syndrome with hypophosphatemic rickets. Dermatology. 2003, 207:72-6. 10.1159\/000070948","journal-title":"Dermatology"},{"key":"ref248","doi-asserted-by":"publisher","DOI":"10.1159\/000509992","article-title":"Schimmelpenning syndrome with large nevus sebaceous and multiple epidermal nevi","volume":"12","author":"Dwiyana RF","year":"2020","unstructured":"Dwiyana RF, Hazari MN, Diana IA, Gondokaryono SP, Effendi RM, Gunawan H. Schimmelpenning syndrome with large nevus sebaceous and multiple epidermal nevi. Case Rep Dermatol. 2020, 12:186-91. 10.1159\/000509992","journal-title":"Case Rep Dermatol"},{"key":"ref249","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2012.00302","article-title":"Generalized arterial calcification of infancy and pseudoxanthoma elasticum: two sides of the same coin","volume":"3","author":"Nitschke Y","year":"2012","unstructured":"Nitschke Y, Rutsch F. Generalized arterial calcification of infancy and pseudoxanthoma elasticum: two sides of the same coin. Front Genet. 2012, 3:302. 10.3389\/fgene.2012.00302","journal-title":"Front Genet"},{"key":"ref250","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.108.797704","article-title":"Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy","volume":"1","author":"Rutsch F","year":"2008","unstructured":"Rutsch F, B\u00f6yer P, Nitschke Y, et al.. Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet. 2008, 1:133-40. 10.1161\/CIRCGENETICS.108.797704","journal-title":"Circ Cardiovasc Genet"},{"key":"ref251","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.911672","article-title":"Case report and review of literature: autosomal recessive hypophosphatemic rickets type 2 caused by a pathogenic variant in ENPP1 gene","volume":"13","author":"Choe Y","year":"2022","unstructured":"Choe Y, Shin CH, Lee YA, Kim MJ, Lee YJ. Case report and review of literature: autosomal recessive hypophosphatemic rickets type 2 caused by a pathogenic variant in ENPP1 gene. Front Endocrinol (Lausanne). 2022, 13:911672. 10.3389\/fendo.2022.911672","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref252","article-title":"McCune-Albright Syndrome","author":"Dean L","year":"2012","unstructured":"Dean L. McCune-Albright Syndrome. Medical Genetics Summaries. Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ (ed): National Center for Biotechnology Information, 2012."},{"key":"ref253","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.09.052","article-title":"Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia","volume":"78","author":"Kobayashi K","year":"2006","unstructured":"Kobayashi K, Imanishi Y, Koshiyama H, et al.. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci. 2006, 78:2295-301. 10.1016\/j.lfs.2005.09.052","journal-title":"Life Sci"},{"key":"ref254","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1993.tb01005.x","article-title":"Erythrodermic psoriasis. Report of a case associated with symptomatic hypophosphataemia","volume":"18","author":"McElhenny BE","year":"1993","unstructured":"McElhenny BE, Todd DJ, McCance D, Young I, Burrows D. Erythrodermic psoriasis. Report of a case associated with symptomatic hypophosphataemia. Clin Exp Dermatol. 1993, 18:167-8. 10.1111\/j.1365-2230.1993.tb01005.x","journal-title":"Clin Exp Dermatol"},{"key":"ref255","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14562","article-title":"Sporadic hypophosphatemic osteomalacia combined with psoriasis: A rare case report and a brief review of the literature","volume":"26","author":"Li Y","year":"2023","unstructured":"Li Y, Chen X, Wang B, Liu X, Hou S. Sporadic hypophosphatemic osteomalacia combined with psoriasis: A rare case report and a brief review of the literature. Int J Rheum Dis. 2023, 26:968-72. 10.1111\/1756-185X.14562","journal-title":"Int J Rheum Dis"},{"key":"ref256","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.5.7745010","article-title":"Oncogenic osteomalacia: evidence for a humoral phosphaturic factor","volume":"80","author":"Wilkins GE","year":"1995","unstructured":"Wilkins GE, Granleese S, Hegele RG, Holden J, Anderson DW, Bondy GP. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab. 1995, 80:1628-34. 10.1210\/jcem.80.5.7745010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref257","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01520.x","article-title":"Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden","volume":"117","author":"Boffetta P","year":"2001","unstructured":"Boffetta P, Gridley G, Lindel\u00f6f B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol. 2001, 117:1531-7. 10.1046\/j.0022-202x.2001.01520.x","journal-title":"J Invest Dermatol"},{"key":"ref258","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.113","article-title":"Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis","volume":"129","author":"Brauchli YB","year":"2009","unstructured":"Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol. 2009, 129:2604-12. 10.1038\/jid.2009.113","journal-title":"J Invest Dermatol"},{"key":"ref259","doi-asserted-by":"publisher","DOI":"10.1186\/s40200-017-0315-5","article-title":"Is there any link between tumor-induced osteomalacia and psoriasis? A case report","volume":"16","author":"Akbari M","year":"2017","unstructured":"Akbari M, Larijani B, Sharghi S, Jalili A, Sajjadi-Jazi SM. Is there any link between tumor-induced osteomalacia and psoriasis? A case report. J Diabetes Metab Disord. 2017, 16:34. 10.1186\/s40200-017-0315-5","journal-title":"J Diabetes Metab Disord"},{"key":"ref260","article-title":"Fibroblast growth factor 23 and placental growth factor in patients with psoriasis and their relation to disease severity","volume":"46","author":"Okan G","year":"2016","unstructured":"Okan G, Baki AM, Yorulmaz E, Do\u011fru-Abbaso\u011flu S, Vural P. Fibroblast growth factor 23 and placental growth factor in patients with psoriasis and their relation to disease severity. Ann Clin Lab Sci. 2016, 46:174-9.","journal-title":"Ann Clin Lab Sci"},{"key":"ref261","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and Inflammation in CKD","volume":"7","author":"Munoz Mendoza J","year":"2012","unstructured":"Munoz Mendoza J, Isakova T, Ricardo AC, et al.. Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol. 2012, 7:1155-62. 10.2215\/CJN.13281211","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref262","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2012.53","article-title":"1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes","volume":"37","author":"Gao D","year":"2013","unstructured":"Gao D, Trayhurn P, Bing C. 1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes (Lond). 2013, 37:357-65. 10.1038\/ijo.2012.53","journal-title":"Int J Obes (Lond)"},{"key":"ref263","article-title":"Oncogenic osteomalacia","volume":"55","author":"Jacob JJ","year":"2007","unstructured":"Jacob JJ, Finny P, Thomas M, Thomas N, John M. Oncogenic osteomalacia. J Assoc Phys India. 2007, 55:231-3.","journal-title":"J Assoc Phys India"},{"key":"ref264","doi-asserted-by":"publisher","DOI":"10.4103\/0971-3026.150155","article-title":"Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis: case report and literature review","volume":"25","author":"Gupta A","year":"2015","unstructured":"Gupta A, Dwivedi A, Patel P, Gupta S. Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis: case report and literature review. Indian J Radiol Imaging. 2015, 25:63-6. 10.4103\/0971-3026.150155","journal-title":"Indian J Radiol Imaging"},{"key":"ref265","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199105000-00006","article-title":"Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis","volume":"301","author":"Konishi K","year":"1991","unstructured":"Konishi K, Nakamura M, Yamakawa H, Suzuki H, Saruta T, Hanaoka H, Davatchi F. Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis. Am J Med Sci. 1991, 301:322-8. 10.1097\/00000441-199105000-00006","journal-title":"Am J Med Sci"},{"key":"ref266","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27302006000400025","article-title":"Hypophosphatemic rickets and osteomalacia","volume":"50","author":"de Menezes Filho H","year":"2006","unstructured":"de Menezes Filho H, de Castro LC, Damiani D. Hypophosphatemic rickets and osteomalacia. Arq Bras Endocrinol Metabol. 2006, 50:802-13. 10.1590\/s0004-27302006000400025","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"ref267","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-9877(02)00254-2","article-title":"Hypophosphatemic osteomalacia in neurofibromatosis 1: hypotheses for pathogenesis and higher incidence of spinal deformity","volume":"59","author":"Abdel-Wanis M","year":"2002","unstructured":"Abdel-Wanis M, Kawahara N. Hypophosphatemic osteomalacia in neurofibromatosis 1: hypotheses for pathogenesis and higher incidence of spinal deformity. Med Hypotheses. 2002, 59:183-5. 10.1016\/s0306-9877(02)00254-2","journal-title":"Med Hypotheses"},{"key":"ref268","doi-asserted-by":"publisher","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart A","year":"2014","unstructured":"Linglart A, Biosse-Duplan M, Briot K, et al.. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect. 2014, 3:R13-30. 10.1530\/EC-13-0103","journal-title":"Endocr Connect"},{"key":"ref269","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcq039","article-title":"Medication-induced hypophosphatemia: a review","volume":"103","author":"Liamis G","year":"2010","unstructured":"Liamis G, Milionis HJ, Elisaf M. Medication-induced hypophosphatemia: a review. QJM. 2010, 103:449-59. 10.1093\/qjmed\/hcq039","journal-title":"QJM"},{"key":"ref270","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00888-1","article-title":"Drug-induced hypophosphatemia: current insights","volume":"43","author":"Megapanou E","year":"2020","unstructured":"Megapanou E, Florentin M, Milionis H, Elisaf M, Liamis G. Drug-induced hypophosphatemia: current insights. Drug Saf. 2020, 43:197-210. 10.1007\/s40264-019-00888-1","journal-title":"Drug Saf"},{"key":"ref271","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.733793","article-title":"Cortisol and phosphate homeostasis: Cushing\u2019s syndrome is associated with reversible hypophosphatemia","volume":"12","author":"Bosman A","year":"2021","unstructured":"Bosman A, van den Beld AW, Feelders RA, Zillikens MC. Cortisol and phosphate homeostasis: Cushing\u2019s syndrome is associated with reversible hypophosphatemia. Front Endocrinol (Lausanne). 2021, 12:733793. 10.3389\/fendo.2021.733793","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref272","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2006.05.001","article-title":"New clinical syndromes in dermatology","volume":"25","author":"Romanelli P","year":"2006","unstructured":"Romanelli P, Bouzari N. New clinical syndromes in dermatology. Semin Cutan Med Surg. 2006, 25:79-86. 10.1016\/j.sder.2006.05.001","journal-title":"Semin Cutan Med Surg"},{"key":"ref273","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/384821","article-title":"Metastatic calcinosis cutis: a case in a child with acute pre-B cell lymphoblastic leukemia","volume":"2015","author":"Castanedo-C\u00e1zares JP","year":"2015","unstructured":"Castanedo-C\u00e1zares JP, Reyes-Herrera A, Hern\u00e1ndez-Blanco D, Oros-Ovalle C, Torres-\u00c1lvarez B. Metastatic calcinosis cutis: a case in a child with acute pre-B cell lymphoblastic leukemia. Case Rep Hematol. 2015, 2015:384821. 10.1155\/2015\/384821","journal-title":"Case Rep Hematol"},{"key":"ref274","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-04841-5.X5001-8","article-title":"Renal Disease and Metabolic Disorders in Critically Ill","author":"Faridi AB","year":"2008","unstructured":"Faridi AB, Weisberg LS. Renal Disease and Metabolic Disorders in Critically Ill. Critical Care Medicine, 3rd edn. Parrillo JE, Dellinger RP (ed): Mosby, New Jersey; 2008. 1203-43. 10.1016\/B978-0-323-04841-5.X5001-8"},{"key":"ref275","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-47871-7.00085-X","article-title":"Disorders of Phosphorus Metabolism","author":"El Kateb","year":"2019","unstructured":"El Kateb , Topf JM. Disorders of Phosphorus Metabolism. Nephrology Secrets, 4th edn. Lerma EV, Sparks M, Topf JM (ed): Elsevier, 2019. 532-38. 10.1016\/B978-0-323-47871-7.00085-X"},{"key":"ref276","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9041694","article-title":"Magnesium and human health: perspectives and research directions","volume":"2018","author":"Al Alawi AM","year":"2018","unstructured":"Al Alawi AM, Majoni SW, Falhammar H. Magnesium and human health: perspectives and research directions. Int J Endocrinol. 2018, 2018:9041694. 10.1155\/2018\/9041694","journal-title":"Int J Endocrinol"},{"key":"ref277","doi-asserted-by":"publisher","DOI":"10.1016\/bs.afnr.2021.01.001","article-title":"Magnesium: The recent research and developments","volume":"96","author":"Al Alawi AM","year":"2021","unstructured":"Al Alawi AM, Al Badi A, Al Huraizi A, Falhammar H. Magnesium: The recent research and developments. Adv Food Nutr Res. 2021, 96:193-218. 10.1016\/bs.afnr.2021.01.001","journal-title":"Adv Food Nutr Res"},{"key":"ref278","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2021.101285","article-title":"A comprehensive review of hypomagnesemia","volume":"68","author":"Ehrenpreis ED","year":"2022","unstructured":"Ehrenpreis ED, Jarrouj G, Meader R, Wagner C, Ellis M. A comprehensive review of hypomagnesemia. Dis Mon. 2022, 68:101285. 10.1016\/j.disamonth.2021.101285","journal-title":"Dis Mon"},{"key":"ref279","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-0537","article-title":"Improving diagnosis and treatment of hypomagnesemia","volume":"62","author":"Salinas M","year":"2024","unstructured":"Salinas M, L\u00f3pez-Garrig\u00f3s M, Flores E, Leiva-Salinas C. Improving diagnosis and treatment of hypomagnesemia. Clin Chem Lab Med. 2024, 62:234-48. 10.1515\/cclm-2023-0537","journal-title":"Clin Chem Lab Med"},{"key":"ref280","doi-asserted-by":"publisher","DOI":"10.1684\/mrh.2019.0450","article-title":"Serum magnesium concentrations in vitiligo patients","volume":"32","author":"Namazi MR","year":"2019","unstructured":"Namazi MR, Nozari F, Jafari P. Serum magnesium concentrations in vitiligo patients. Magnes Res. 2019, 32:51-3. 10.1684\/mrh.2019.0450","journal-title":"Magnes Res"},{"key":"ref281","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290026367","article-title":"Hypomagnesemia and hypocalcemia in mycosis fungoides: a retrospective case series","volume":"43","author":"Morgan M","year":"2002","unstructured":"Morgan M, Maloney D, Duvic M. Hypomagnesemia and hypocalcemia in mycosis fungoides: a retrospective case series. Leuk Lymphoma. 2002, 43:1297-302. 10.1080\/10428190290026367","journal-title":"Leuk Lymphoma"},{"key":"ref282","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.supplement1.s167","article-title":"Magnesium and the pathogenesis of toxic shock syndrome","volume":"1","author":"Kass EH","year":"1989","unstructured":"Kass EH. Magnesium and the pathogenesis of toxic shock syndrome. Rev Infect Dis. 1989, 1:167-73. 10.1093\/clinids\/11.supplement1.s167","journal-title":"Rev Infect Dis"},{"key":"ref283","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12293","article-title":"The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients","volume":"23","author":"van Smeden J","year":"2014","unstructured":"van Smeden J, Janssens M, Kaye EC, Caspers PJ, Lavrijsen AP, Vreeken RJ, Bouwstra JA. The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients. Exp Dermatol. 2014, 23:45-52. 10.1111\/exd.12293","journal-title":"Exp Dermatol"},{"key":"ref284","article-title":"Characteristics and partial purification of a novel cytosolic, magnesium-independent, neutral sphingomyelinase activated in the early signal transduction of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation","volume":"11","author":"Okazaki T","year":"1994","unstructured":"Okazaki T, Bielawska A, Domae N, Bell RM, Hannun YA. Characteristics and partial purification of a novel cytosolic, magnesium-independent, neutral sphingomyelinase activated in the early signal transduction of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem. 1994, 11:4070-7.","journal-title":"J Biol Chem"},{"key":"ref285","doi-asserted-by":"publisher","DOI":"10.5414\/TEX01421","article-title":"\u200bSerum magnesium in atopic patients with special reference to atopic dermatitis\u200b","volume":"33","author":"Rattanatayarom W","year":"2016","unstructured":"Rattanatayarom W, Udompataikul M, Arayaskul S, Classen A, Classen HG. \u200bSerum magnesium in atopic patients with special reference to atopic dermatitis\u200b. Trace Elements Electrolytes. 2016, 33:74-8. 10.5414\/TEX01421","journal-title":"Trace Elements Electrolytes"},{"key":"ref286","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2004.00660.x","article-title":"Idiopathic diffuse alopecias in young women correlated with hypomagnesemia","volume":"18","author":"Tataru A","year":"2004","unstructured":"Tataru A, Nicoara E. Idiopathic diffuse alopecias in young women correlated with hypomagnesemia. J Eur Acad Dermatol Venereol. 2004, 18:393-4. 10.1111\/j.1468-3083.2004.00660.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref287","doi-asserted-by":"publisher","DOI":"10.1016\/s0738-081x(97)00209-5","article-title":"Management of acute attacks in the porphyrias","volume":"16","author":"Kalman DR","year":"1998","unstructured":"Kalman DR, Bonkovsky HL. Management of acute attacks in the porphyrias. Clin Dermatol. 1998, 16:299-306. 10.1016\/s0738-081x(97)00209-5","journal-title":"Clin Dermatol"},{"key":"ref288","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21276","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue","volume":"28","author":"Schwartz J","year":"2013","unstructured":"Schwartz J, Winters JL, Padmanabhan A, et al.. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013, 28:145-284. 10.1002\/jca.21276","journal-title":"J Clin Apher"},{"key":"ref289","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00247.x","article-title":"Profound ionized hypomagnesemia induced by therapeutic plasma exchange in liver failure patients","volume":"42","author":"Kamochi M","year":"2002","unstructured":"Kamochi M, Aibara K, Nakata K, et al.. Profound ionized hypomagnesemia induced by therapeutic plasma exchange in liver failure patients. Transfusion. 2002, 42:1598-602. 10.1046\/j.1537-2995.2002.00247.x","journal-title":"Transfusion"},{"key":"ref290","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.71","article-title":"Multiplex epithelium dysfunction due to CLDN10 mutation: the HELIX syndrome","volume":"20","author":"Hadj-Rabia S","year":"2018","unstructured":"Hadj-Rabia S, Brideau G, Al-Sarraj Y, et al.. Multiplex epithelium dysfunction due to CLDN10 mutation: the HELIX syndrome. Genet Med. 2018, 20:190-201. 10.1038\/gim.2017.71","journal-title":"Genet Med"},{"key":"ref291","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2010.533676","article-title":"Survival after hypocalcemia, hypomagnesemia, hypokalemia and cardiac arrest following mild hydrofluoric acid burn","volume":"48","author":"Wu ML","year":"2010","unstructured":"Wu ML, Deng JF, Fan JS. Survival after hypocalcemia, hypomagnesemia, hypokalemia and cardiac arrest following mild hydrofluoric acid burn. Clin Toxicol (Phila). 2010, 48:953-5. 10.3109\/15563650.2010.533676","journal-title":"Clin Toxicol (Phila)"},{"key":"ref292","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701444670","article-title":"Non-fatal ventricular dysrhythmias associated with severe salicylate toxicity","volume":"46","author":"Kent K","year":"2008","unstructured":"Kent K, Ganetsky M, Cohen J, Bird S. Non-fatal ventricular dysrhythmias associated with severe salicylate toxicity. Clin Toxicol (Phila). 2008, 46:297-9. 10.1080\/15563650701444670","journal-title":"Clin Toxicol (Phila)"},{"key":"ref293","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2000.12.6.463","article-title":"Amphotericin B-induced nephrotoxicity: a review","volume":"12","author":"Fanos V","year":"2000","unstructured":"Fanos V, Cataldi L. Amphotericin B-induced nephrotoxicity: a review. J Chemother. 2000, 12:463-70. 10.1179\/joc.2000.12.6.463","journal-title":"J Chemother"},{"key":"ref294","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.829","article-title":"An overview of diagnosis and management of drug-induced hypomagnesemia","volume":"9","author":"Liamis G","year":"2021","unstructured":"Liamis G, Hoorn EJ, Florentin M, Milionis H. An overview of diagnosis and management of drug-induced hypomagnesemia. Pharmacol Res Perspect. 2021, 9:e00829. 10.1002\/prp2.829","journal-title":"Pharmacol Res Perspect"},{"key":"ref295","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092094","article-title":"Magnesium and Drugs","volume":"20","author":"Gr\u00f6ber U","year":"2019","unstructured":"Gr\u00f6ber U. Magnesium and Drugs. Int J Mol Sci. 2019, 20:10.3390\/ijms20092094","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/337325-a-comprehensive-review-of-electrolyte-imbalances-and-their-applied-aspects-in-dermatology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T14:27:46Z","timestamp":1743172066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/337325-a-comprehensive-review-of-electrolyte-imbalances-and-their-applied-aspects-in-dermatology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":295,"URL":"https:\/\/doi.org\/10.7759\/cureus.81353","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}